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Chapter 1
INI'RODUCTION

~

Iransition-state analog theory
Collision theory calculates the probability for formation of an

activated chemical state using ordinary statistical mechanics. This
probability for formation of an activated state multiplied by the rate
of decomposition gives the rate of a chemical reaction (Eyring, 1935).
The theory need not consider the size or the geometrical shape of the
colliding molecules. A more sophisticated treatment to the structurereactivity relationship in chemical reaction rate is given in the
transition state theory. The two salient differences of this theory from
the "collision theory" are that the way in which the reactants collide
is totally ignored, and only two physical states considered are the
ground state and the most activated-state on the reaction pathway. In
this dissertation the combination of the transition state theory and
knowledge of mechanism of protease catalysis will result in development
of a powerful technical tool, an affinity chromatography ligand for the
selective purification of proteolytic enzymes.
Originally Pauling (1948) proposed that an enzyme has a
configuration complimentary to the substrate in its activated state, and
as a result will have higher affinity to the substrate's activated state
(transition state) than to its ground state. This prediction of higher

1

2

affinity for the transition state comes from a straight forward
argument made from the scheme depicted in Fig.1. A unimolecular
conversion of a reactant, S, to a product, P, will occur by the reaction
pathway with the lowest energy barrier. The structure of the highest
energy on this lowest energy pathway is designated the transition state,

sf'.
The top of Figure 1 shows the reaction of the substrate, S,
reacting to product, P, in a reaction not catalyzed by enzyme, E. The
bottom of the Figure-1 shows the same reaction catalyzed by enzyme, E,
through transition state, ES#. Accordingly Ks is the equilibrium
constant for association of substrate with the enzyme; K#N and K#E, the
equilibrium constants for formation of the nonenzymic and enzymic
transition states, s# and ES#, respectively; and KT the equilibrium
association constant for association of the substrate in its transition
state configuration to the enzyme. Based on the definitions for the
respective equilibrium constants in Fig-1, it is easily shown that they
are related by equation-1.

=

( 1)

In the transition state chemical bonds are in the process of being
made and broken. The rate at which the transition state decomposes is
the same as the vibrational frequency v of the bond which is being
broken. The rate of reaction is therefore obtained from the transition

3

E +

ES

S

Jd'N

~==:!'

<
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p
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p

E

Figure 1: Thermodynamic schematic representation of the
''Transition-state Theory" as applied to enzymatic
catal ys i~. See text for detail.

L:

state theory (Lienhard, 1973) by multiplying the concentration of the
transition state by the rate constant for decomposition. Based on a
derivation from quantum theory (E:hv) and classical physics (E:kT) the
first order rate equation will be as shown by equation-2.

d(P)
kT
- - = -(S/1)
h
dt

kT
: -KII N(S)

= kn(S)

(2)

h

where kn is the first order rate constant for non-enzymic reaction, k
the Boltzman constant, T, the absolute temperature and h the Plank's
constant. A similar equation can be written for ke and K11 or ES11 in the
enzymic pathway. Combining equations (1) and (2) gives equation (3).

=

(3)

where ke/kn is the ratio of the first order rate constant for the
enzymic and non-enzymic reaction. It is commonly believed that the ratio
ke/kn is at least 108 (Schultz and Cherva, 1975). Transition state
theory gives no information about the extent of similarity in structure
between the transition state of the non-enzymic reaction, sll, and the
substrate portion of the transition state of the enzymic reaction.
However, regardless of the extent of similarity, equation (3) may be
valid (Lienhard, 197 3).
Equation (3) indicates that the equilibrium association constant

5
ror binding of the transition state s# to the enzyme, KT, will be at
least 8 orders of magnitude larger than the association constant for the
binding of substrate itself, K8• Generally the value 108 is not
observed, but many examples have been shown of a higher affinity for
transition-state analogs to an enzyme active site than for an enzyme's
substrates (Table-1) (Lienhard, 1973; Wolfenden, 1972; Wolfenden, 1976;
Schray and Klinman, 1974; Lindquist, 1975).
The purification of proteolytic enzymes from complex biological
systems is often difficult, especially when the concentration of the
enzyme is low and multiple enzymes with an identical primary binding
site specificity are present. Pancreatic proteases were the first
proteinases purified in the late 20's and 30's by Sumner and Howell. The
major method of purification was by fractional crystallization. In these
cases the starting protease had to be present in concentrations from
milligram to gram quantities. Current conventional chromatographic
techniques primarily utilize the principals of gel filtration and ionexchange chromatography. These methods are non-specific and tedious. A
more specific form for the purification of proteases is affinity
chromatography. The ligands used in affinity resins for protease
purification are general inhibitors, cofactors or substrate analogs.
More recently antibodies to a particular protease enzyme have been
successfully employed in purification of proteases. In many cases the
small inhibitors or substrate analogs do not have high binding
constants or high selectivity with the protease.In dilute solutions of
enzyme,

the concentration of enzyme is often too low to bind in

Table 1
CCJWARISON OF PROPOSED TRANSITION STATE ANAI..(X; INHIDITON CONSTANTS (K ) wmt
RESPECTIVE SUBSTRATE MICHAELIS CONSTANTS (~) TO SELECTED HYDROLASE ERZIMES

Enzyme
Lysozyme
-Glucosidase (yeast)
-Glucosidase (yeast)

Inhibitor, KI, or Substrate,

~.

M

(N-acetylgalactoseamine) 4-lacton5, 3x1o-7
(N-acetylgalactoseamine) 4 , 1x10-

102

1-aminoglucoside, 2.3x10-6
p-nitrophenyl-glucoside, 1.4x1or4

1o2

1-aminogalactoside, 1.6x1or4
p-nitrophenyl-galactoside, 1.7x1o-2

1o2

Carboxypeptidase-A

L-benzylsuccinat~, 4.5x1or7
Cbz-L-Phe, 8x10"'"

Elastase

N-Acetyl-Pro-Ala-Pro-alaninal, 8x1o-7
N-Acetyl-Pro-Ala-Pro-AlaOMe, 1.5x1o-3

Papain

N-Acetyl-Phe-Glycinal, 4.6x1g-8
N-Acetyl-Phe-GlyOMe, 3.2x10"'"

Subtilisin

Benzeneboronic acid, 8x1Qr4
N-Acetyl-TyrOEt, 9.0x1~

Amidase

Acetaldehyde-NH~, a.6x1o-5
Acetamide, 8.3xTO"'"

W.P. Kennedy. 1980.
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considerable yield. Antibodies have been used as ligands to alleviate
the problem of low binding constant. However, antibodies are difficult
to produce. More importantly, often severe conditions are required to

dissociate the protease from the antibody, which may result in the
irreversible denaturation of the protease (Scouten, 1974).

~

peptide aldehydes

~

ligand in affinity resins.

In the case of the serine proteases, the mechanism of substrate
catalysis has been shown to go through an acylserine intermediate (ES')
in a scheme depicted by equation 4; where ES is the Michaelis complex,
k2 the first order rate constant for formation of the acylserine
intermediate from ES, k3 the pseudo first order rate constant for
hydrolysis of the acylserine intermediate, P1 the first product of the
reaction (amine or alcohol), and P2 the second (acid) product of the
reaction (Bender and Kezdy, 1964; Henderson, 1970).

(4)

A non-covalent intermediate is formed first between substrate and
enzyme followed by the attack of the hydroxyl of the serine active site
on the substrate to give an acylserine intermediate, releasing the amine
or alcohol (step k2 ). The acylenzyme is then hydrolyzed to form the
enzyme and second product (step k3). The transition state configuration
for the hydrolyzable peptide (or ester) carbonyl carbon in steps k2 and

8
k is thought to be tetrahedral (sp3) (see fig-3) (Kraut, 1969; Roburtus
3
~ a1., 1972). X-ray crystallographic studies of the enzyme-substrate
binding complex of various polypeptides to subtilisin BPN' using a
difference-Fourier method and model building experiments suggest that
the carbonyl carbon assumes a tetrahedral conformation in the transition
state, as this results in more favourable contacts between the
substrate specificity residue P1 and the enzyme. The enzyme active site
can form four hydrogen bonds to stabilize the transition-state and
thereby lower the free energy of activation for reaction (Robertus

~

a1u 1972). In addition, structural data indicate the binding of leaving
I

groups at P1 and hydrogen bonds to the carbonyl group of the scissile
bond, are better oriented when the carbonyl carbon becomes tetrahedral
(Blow

~ ~

1974). Accordingly, substrate analogs that place the

proper charge distribution and stereochemistry around the carbonyl
carbon, that is an sp3 configuration in the catalytic site, may mimic
features of the transition state configuration and will be expected to
associate with extremely high affinity (Wolfenden, 1969).
Peptidyl aldehyde substrate analogs may present an sp3 C-1
configuration to the active site of protease enzymes when associated as
the hydrated adduct IB or as a covalent hemiacetal IIA or IIB (Fig.2),
and thus may be predicted to associate with high affinity as a
transition state analog. In agreement with the prediction, it has been
found that specifically designed natural and synthetic peptide aldehydes
associate 102 to 10 4 times better to serine proteases than their
analogous substrates (Kennedy and Schultz, 1979; Aoyagi and Umezawa,
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Figure 2. Scheme for association of peptide aldehyde with the active
site of SERINE proteases: IA and IB are Michaelis complexs with the C-1
carbonyl carbon of the aldehyde in spf and sp3 configurations,
respectively; IIA and IIB are hemiacetal adducts with the active site
Ser-195 of the enzyme. In the hemiacetal adducts IIA and IIB the C-1
carbonyl carbon of the aldehyde also has a sp3 configuration as in the
transition state of the substrate reactions catalysed the protease
enzyme.

1()
1975; Thompson, 1973; Westerick and Wolfenden, 1972; Frankfater and
KuppY, 1981 ) •
In future discussions the nomenclature introduced by Schechter and
Burger (1967) will be used as follows: the substrates are lined up with
the enzyme in such a way that the hydrolyzing CO-NH group occupies
the catalytic site; the amino acid residues of the substrate each occupy
adjacent subsites in the enzyme, those towards the NH2-terminal occupy
subsites

s1,

S2,

s3,

etc., those towards the COOH-terminal of the

substrate occupy subsites S' 1, S'2 , S'3 etc of the enzyme. The positions
of the residues in the substrates are numbered P1, P2,P3 or P' 1, P'2'
p'

3

according to the subsites they occupy.
Umezawa initiated the study of peptide aldehydes with the

discovery of the leupeptins from Actinomycetes culture medium. The
leupeptins are inhibitors of trypsin-like (proteases specific to
arginine or lysine in the primary binding site, P1) proteases (Aoyagi ~
~ 1969). These inhibitors were shown to be peptide aldehydes in which
the carboxylic group is reduced to an aldehydic group. These were the
first examples of peptide aldehyde competitive inhibitors of serine
proteases. Aldehyde inhibitors are turned over by protease enzymes in a
similar way to normal substrates (Kennedy and Schultz, 1979). They
reversibly form an acyl serine type adduct, which decomposes to a
product that is the same as starting substrate (Kennedy and
Schultz,1979). This assures a constant concentration of the peptide
aldehyde inhibitor in solutions of inhibitor and enzyme. If a peptide
aldehyde is used as a ligand in affinity resin it may therefore be
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expected that this resin could bind serine proteases effectively by

forming a reversible covalent adduct with the protease of high affinity.
Many interesting serine proteases such as these involved in thrombolytic
and fibrinolytic processes have a primary specificity for arginine.
Argininal affinity resin should bind these serine proteases containing a
primary site (P 1) specificity for arginine.
Currently utilized protease affinity resins for arginine specific
proteases utilize ligands such as benzamidine and lysine with binding
constants to protease enzymes of 5x1o- 4 M to 1x1o-2 M (Holmberg ~ ~
1976). In contrast the peptidyl aldehyde ligands have affinity constant
2 to 7 orders of magnitudes higher than these commonly utilized ligands.
Because of the higher affinity of the peptidyl aldehyde ligand, dilute
proteases

may be purified with significantly higher yields.

Investigations on the secondary specificity of trypsin-like
proteases show that variation of the amino acid sequence
N-terminal to the P1 residue in the substrate can lead to the ability
of a substrate to be hydrolyzed selectively by a particular plasma
protease within a group of plasma proteases. Accordingly, the peptide
p--nitroanilide H-D-Phe-Pro-Arg-pNA

is selective substrate of thrombin.

It may be suggested that D-Phe-Pro-Argal would be a selective inhibitor
of thrombin (Bajusz

~ ~'

1978). While the benzamidine and lysine

sepharoses do not show any dramatic specificity or selectivity between
different plasma proteases with trypsin-like specificity, the selective
affinity of the peptidyl aldehydes can be used for the purification of
an individual specific protease within a biological pathway. Thus X-Y-

12
Argininal affinity resins can be designed for the purification of a
particular protease among a group of proteases with a primary site
specificity towards arginine.

~

~

Q(

~

Dissertation

The major objective of my research is to exploit the thermodynamic
predictions of the transition-state theory for the practical purpose
of protease purification utilizing highly selective and specific
peptidyl aldehydes. The application of this technique will have a
general usefulness in the isolation and purification of biologically
important proteases. In this Disertation I will:
(1) Synthesize tripeptidyl aldehyde ligand affinity resins of the
general formula R-X-Y-Argininal where R- is the resin matrix and
X-Y is a dipeptide. Methods are developed to bind and dissociate
protease enzymes to these resins and selectively separate a particular
trypsin-like protease.
(2) Show progress towards development of a develop general procedure
for the purification of proteases in which the substrate of the protease
is attached by its N-terminal residue to an inert support, treated with
a biological solution containing the protease activity to be purified,
. and the COOH-terminal of the peptide fragment chemically modified to a
peptidyl aldehyde to generate the transition state analog inhibitor of
the protease of interest. This affinity resin is evaluated for the
selective purification of the protease that was used to generate the
acid ligand product. By this procedure, an unknown protease can be
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purified from complex biological systems based solely on the
availability of its substrate.
In this research the examples of thrombin and urokinase are used to
demonstrate what I view as general procedures of protease purification.
It is hoped that establishing of the general procedure will allow other
workers to utilize these techniques in their own work, with their
protease of interest.

Chapter 2
REVIEW OF THE RELATED LITERATURE

~

Protease purification and mechanism

Q(

action

Q(

serine proteases.

The mechanism of action for enzymes was proposed even before it was
known that enzymes are proteins. For example important kinetic studies
on cell free extracts of enzymes were carried out by Buchne in 1897. It
wasn't until 1935 that the first enzyme was crystallized by Northrop and
Kunitz, producing enough pure enzyme to prove that the enzymes were
proteins (Northrop and Kunitz, 1939). Purification by crystallization is
useful only when the protease is present in large quantity. When the
quantity of enzyme is low and the matrix from which the protease is to
be purified is complex, chromatographic techniques become essential. For
the purification of bovine pancreatic trypsin, Chao (1965) used

eM-

cellulose in citrate buffer at pH 4.8. Three years later Schroder (1968)
used sulfonyl Sephadex to separate five different active forms of
trypsin. In the last twenty five years, since its introduction by Porath
(1959), gel-filtration has occupied a key position in the purification
of hundreds of enzymes. A comprehensive review of literature on the use
of gel-filtration and ion-exchange chromatographic techniques by various
researchers is beyond the scope of this dissertation.
Serine proteases are a class of proteases containing a uniquely
reactive serine residue that is primarily responsible for their
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lS
catalytic activity. A general criterion of the serine proteases class is
that they react irreversibly with organophosphates such as diisopropyl
fluorophosphate (Jansen, 1949) with complete loss of its proteolytic
activity. The pH maxima of most extracellular serine proteases is around
7.8 with a group of pKa

=6.8

controlling activity. Modification studies

using N-tosyl-L-phenylalanine chloromethyl ketone by Schollmann and Shaw
(1963) indicated that the group of pKa 6.8 is a histidine. The X-ray
studies (Blow and Steiz, 1970) showed that His-57 (chymotrypsin
numbering) is within H-bonding distance of the active site serine-195. A
third important group shown by X-ray crystallography studies to be
present at the active site of serine proteases is belived to be an
aspartic acid residue (Asp-102).
By early 1960's utilizing innovative kinetic and analytical
techniques, the basic features of the mechanism of action of serine
proteases on amide and ester substrates was elucidated (Bender

~ ~

1964; Zerner and Bender, 1964; Kezdy fi.s.l....., 1964; He conn fi.s..l..., 1971;
Fersht, 1971; Fastrez

~ ~

1971; Mackenzi,

~ ~

1984; Nakagawa and

Umeyama, 1984). The details of the evidences in support of the mechanism
have been thoroughly reviewed (Bender and Kezdy, 1965). The accepted
reaction sequence for serine proteases is as shown in Fig.3 (Kraut,
1977).
The initial step in the reaction pathway is the formation of a
reversible non-covalent intermediate (the Michaelis complex) with
dissociation constant, Ks, between substrate and protease. In a second
step, nucleophilic attack at the substrate scissile carbonyl carbon by
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Figure-3. The reaction sequence for serine proteases.
(Kraut, 1977).

k3 HY
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an active site serineJ'OH residue results in the formation of an acylenzyme intermediate concomitant with the release of an alcohol or amine
product. In the third step (step k3), water acts as the nucleophile in
the hydrolysis of the acyl enzyme intermediate, regenerating the free
enzyme and releasing the acid product.
The focal point of the future discussion will be the carbonyl
carbon

<c 1) of the substrate undergoing hydrolysis. As we shall see

there is considerable evidence for the occurrence of a tetrahedral
intermediate in serine protease-catalyzed hydrolysis. Earlier it was
shown that non-enzymatic acyl substitution reactions with carbon-oxygen
fission generally occur through the formation of an acyl-nucleophile
adduct in which the carbonyl carbon assumes a tetrahedral configuration
(Bender, 1960). From the kinetic study of chymotrypsin catalyzed
hydrolysis of p-nitrophenyl thiolacetate and p-nitroanilide, Frankfater
and Kezdy suggested of necessitating the existence of an intermediate in
which the carbonyl carbon most likely to assume a tetrahedral
configuration (Frankfater and Kezdy, 1969). It was also suggested by
Caplow (1969) that the carbonyl carbon of the substrate assumes sp3
configuration in proposed transition state similar in structure to the
putative tetrahedral intermediate, during formation of acyl enzyme
intermediate. X-ray crystallography with difference-fourier calculations
and model building to the active site also suggest that the carbonyl
carbon assumes a tetrahedral configuration (Kraut, 1977; Robertus,
1972). X-ray diffraction studies at high resolution, 1.8 A0 , of
Streptomyces griseus with a peptide aldehyde also showed the existence

of tetrahedral conformation for the aldehyde in the active site,
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supporting the stability of the sp3 conformation in substrate hydrolysis
(James .tl. .aJ......, 1980).
In addition to the X-ray crystallography, spectrophotometric
techniques such as laser Raman spectroscopy and 13c NMR has provided
evidence for formation of tetrahedral conformation. Hess and Seybert
(1975) using chymotrypsin and phenylethane boronic acid with laser Raman
spectroscopy showed a band at 684 cm- 1 present in the spectra of the
crystalline enzyme inhibitor complex, which indicates a tetrahedral
configuration for the boronic acid in the enzyme.

Additional evidence

for formation of a tetrahedral intermediate in protease enzymes with
transition-state analog inhibitors will be reviewed in the transition
state analog section.

~

Inhibitors

Q[

Serine Proteases

The knowledge of the primary specificity for a protease in its
hydrolysis of peptide bonds provides the starting point for the
development of substrate related synthetic inhibitors. Specificity is
primarily determined by the side chain of the amino acid contributing
the carbonyl function to the bond to be split. Chymotrypsin requires an
aromatic or bulky nonpolar side chain, in r 1 while trypsin requires a
lysine or arginine residue in P1• X-ray studies have shown that these
different substrate specificities arise from structural changes in the
enzyme binding site. In trypsin-like proteases, one residue in the
binding pocket is an aspartate. This aspartate can form a strong
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electrostatic bond with a positively charged lysine or arginine side
chain of a substrate. Accordingly non-substrate compounds that similarly
contain a positively charged group, either amidinium or guanidinium will
be expected to bind preferentially trypsin-like proteases at the active
site and hence act as competitive inhibitors. Thus Guia and Shaw (1965)
showed that benzamidine, p-aminobenzamidine, phenylguanidine,
cyclohexylcarboxamidine, cyclohexylguanidine, 2-phenylacetamidine and
acetamidine are competitive inhibitors of trypsin (Table 2).
Benzamidine and p-aminobenzamidine were the first examples of the
most potent small molecular competitive inhibitors of trypsin. They are
approximately the same size as the side chain of lysine or arginine.
Many other compounds with a positively charged group and a hydrophobic
moiety have also been found to possess an inhibitory effect. These are
alkyl and aryl guanidines, amidine and agmatine derivatives, benzoyl and
tosyl arginine, aliphatic and aromatic amines, and p- or w-amino
carboxylic acids (Keil, 1971). The reversible binding property of these
small inhibitors have been exploited to map the spatial arrangements at
the specificity site of the proteases. Table-3 shows the Ki values of
variety of low molecular weight compounds containing guanidine group for
thrombin (Geratz and Tidwell, 1977). From the data it is evident that
the ring system other than benzene achieve an even tighter fit with the
enzyme, most likely due to improved hydrophobic interaction. The
introduction of a pyruvic acid group in the

~

position to the amino

side chain augmented the inhibitory activity not only in thrombin but
also with plasmin, trypsin and enterokinase (Geratz and Tidwell, 1977).
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Table 2
Competitive inhibitors of trypsin at pH 8.15 and 15 °C
Inhibitor

8.25x1<r6

1.8x1o-5

7.25x1o-5

1.51x1o-2

1.511x1o-3

Guia and Shaw (1965)
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Table-3
Thrombin inhibitors restricted to the
specificity pocket of the enzyme

--------------------------------------------------------------Compound
Structure
--------------------------------------------------------------12.3x1o-3

Benzyl amine

Phenylguanidine

~C-NH

HN

H2 N/

-<0)
0

Benzamidine

2.2x1o- 4

p-Aminophenylpyruvic acid

6.5x1o-6

,S-Napthamidine

8.5x1o-5

5-Amidinoindole

·-------------------------------------------------------------Geraz

~t

,al.,

( 1977).
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Initially the development of more active inhibitors directed towards
trypsin-like proteases beyond primary specificity pocket was chiefly a
empirical process. It consisted of the attachment of a number of
different side chains to the starter compound which in most cases were
represented by benzamidine. The substituents chosen were aliphatic,
aromatic, arylaliphatic, bicyclic or heterocyclic in nature.
Even though substituted benzamidines can differentiate between two
different enzymes from different specificity classes, like chymotrypsin
and trypsin, they will fail to differentiate the enzymes in the same
class, for example between thrombin and trypsin. Rather than an
empirical process for designing low molecular weight inhibitors, the use
of small peptides and peptide derivatives is more logical. To obtain
additional direct information about the binding sites of proteases
outside of the primary binding site, reactive polypeptide inhibitors
were designed. For example Schollmann and Shaw (1962) in developing
chloromethyl ketone inhibitors combined N-tosyl-L-Phe to confer affinity
to the primary active center and halomethyl ketone grouping to achieve
irreversible alkylation of active site histidine. It was predicted that
the increasing the peptide length to dipeptide and tripeptides can lead
to higher specificity.

Morihara and Oak (1970) showed that on

incubation of two different chloromethyl ketone derivatives of peptide
substrates, CBZ-L-Ala-L-Phe and CBZ-L-Ala-Gly-L-Phe with subtilisin, a
much higher rate of inactivation of the enzyme was observed compared to
chloromethyl ketone of CBZ-L-Phe. During the same period Powers and
Wilcox (1970) reported the synthesis of specific peptide chloromethyl
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ketones for chymotrypsin and showed an inhibition of crystal growth.
Thompson and Blout (1973) also showed that three different peptide
chloromethyl ketones differ markedly in their ability to inactivate the
elastase with the longer peptides reacting more rapidly. Thompson and
Blout (1970) reported large increase in the esterase, amidase and
peptidase activities of elastase 4x10 6 fold on increasing the length of
peptide substrate from one to five amino acids N-terminal from the
scissile bond. Too much increase in the length of the peptide also could
be counter productive in case of inappropriate folding of the peptide.
Table 4 shows binding constants of natural and synthetic peptides to
thrombin. Scheraga ( 1977), and Blomback ll. .al..... ( 1977) have shown that
I

while large segments of the residues P16 through P 35 of the fibrinogen
are required for high peptidase activity by thrombin, the equilibrium
binding constants (Km or Ks) for small peptide segments or synthetic
peptide analogs of fibrinopeptide-A may be as good or better than that
for the natural substrate fibrinogen (Table-4). From the binding
constants it could be seen that small peptides up to penta peptide
inhibitors bind better than its natural substrate and CNBr digestion
products.
Plasma proteases involved in coagulation processes and fibrinolytic
processes like thrombin, urokinase, kallikrein etc. have a primary
· specificity for arginine, and are therefore grouped in the class of
trypsin-like proteases. Investigations on the secondary site
specificities of these trypsin-like proteases show that oligopeptide
substrates having the appropriate amino acid sequence N-terminal to the
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Table 4
Binding constants of natural and
synthetic polypeptides to thrombin
Polypeptide
Fibrinogen (natural substrate)

1.2x1cr5a, 3x1o-6b

CNBr-A( )

(human)c

4.7x1cr5

CNBr-B( )

(bovine)d

1.9x1o-4

Synthetic peptide chloromethylketones:e
Gly-Val-ArgCH2Cl

1 .3x1cr5

Val-Pro-ArgCH2Cl

6.7x1cr7

Phe-Ala-ArgCH2Cl

2.9x1o-6

Phe-Ala-LysCH2Cl

3.7x1o-5

H-D-Pro-Phe-Arg-OH

1x10-6

a At pH-9 from K in which rate of fibrinogen cgnversion to
fibrin followed ~y light scattering technique.
At pH-7.4
from Km in which rate of fibrin conversion followed by
appearance of fibrinopeptiges by R.I.A. c Residues 1 through
51 in fibrinogen A-chain.
Residues 1 through 115 in
fibrinogen B-chain. e Determined from Ks in the study of
rates of thrombin modification by chloromethylketones.

Richard M. Schultz N.I.H grant application (HL24910).

r
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p residue could be selectively hydrolyzed by a particular plasma
1
protease within a mixture of related enzymes (Fareed ~ ~ 1981;

Cleason and Aurell, 1981). Table-5 shows specific activity of various
plasma proteases against various synthetic chromogenic substrates.
Because these are trypsin-like proteases, the presence of either
arginine or lysine in the P1 position is essential for primary
specificity. Variation of the amino acid sequence of residues in
positions P2 through P4 in small peptide substrates leads to the ability
to selectively react with one of the plasma proteases in the presence of
other trypsin-like plasma proteases.
The design of small peptide inhibitors thus relies on the knowledge
of the required amino acid sequence around the scissile bond (Kettner
~

~

1980). Hegeman and Scheraga studied the sequence around the Arg-Gly

bond in fibrinogen hydrolysis by thrombin to define the required
structural elements for the optimum thrombin-fibrinogen interaction.
Blomback

~ ~

(1977) also independently came to a common conclusion

that amino acids 1 to 51 in A chain contain all the necessary elements
for optimal interaction. To construct a 51 amino acid residue long
peptide inhibitor could be a very difficult task. The approach taken by
Thompson and Blout (1973b) seems to be a more practical approach. They
synthesized a number of peptide amides for elastase mimicing the natural
substrate elastin, and measured kinetic parameters for the elastase
catalyzed hydrolysis of dipeptides to pentapeptides. By comparing Ki
values they identified

s3

as the subsite unable to bind proline. The

contributions from subsites s5 to s2 towards interaction between enzyme

Table 5
Relative activities of trypsin-like proteases towards different substrates

----

-P:rP -P - -

2 1
----------

Bz-Phe-Val-Arg-pNA

Relative activity of the enzyme
Thrombin

Factor Xa Plasma
Glandular Plasmin Urokinase
Kallikrein Kallikrein

0.1lt0

0.002

0.004

0.001

0.002

0.001

Bz-Ile-Glu-Gly-Arg-pNA 0.005

0.200

0.005

0.003

o.otli

0.007

D-Phe-Pip-Arg-pNA

0.480

0.008

0.007

0.004

0.002

0.002

D-Val-Leu-Lys-pNA

0.002

0.001

0.007

0.020

O.OitO

0.000

D-Val-Leu-Arg-pNA

0.005

0.001

0.006

0.130

0.002

0.001

D-Pro-Phe-Arg-pNA

0.030

O.OitO

0.190

0.100

0.040

o.ooo

~lu-Gly-Arg-pNA

0.620 0.003 0.004 0.001

A.B Kabi, Blood product divjsion, Sweden.

0.001

0.001

0.040

,
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and substrate was shown to be sufficient for practical purposes, and
interactions beyond s5 could be safely ignored for the design of a
peptide inhibitor. In case of thrombin-fibrinogen system, important
contribution to binding are made by residues relatively far from the
scissile bond within the structure such as the Phe in P9 and Asp in P10
positions. When the substrate is folded in a helical structure, the
ninth position N-terminal becomes close to the s3 position (Marsh ~
~ 1982; 1983). Accordingly, the peptide aldehyde H-D-Phe-Pro-Argal in
which a hydrophobic residue at position 3 in a D conformation, is found
to be able to mimic the Phe in position 9 of the normal substrate and to
be a selective and potent tripeptide inhibitor of thrombin (Bajusz
~

~

1978). This peptide inhibitor is thus designed on the basis of one

of the products of thrombin hydrolysis, namely the N-terminal segment of
substrate (P 2 in eq. 4).
Design of the peptide inhibitors based on a substrate which
spans the active site on both directions i.e. N-terminal and C-terminal
of the scissile bond, have also been investigated (Szelke

~ ~

1982).

A strategy involved in designing these inhibitors is to reduce the
succeptible amide bond to the -CH2-NH- moiety. Since the protease can
not hydrolyze -CH2-NH- bond, the peptide inhibitor is termed as nonhydrolyzable isosteric peptide inhibitor. For example a number of such
inhibitors for renin are synthesized by Szelke

~ ~

(1982). The

inhibitor designed in this way H-Pro-His-Pro-Phe-His-Leu-R-Val-Ile-HisLys-OH is 30,000 times more active than the human octapeptide from which
it was derived. It is argued that the greatly enhanced renin inhibitory
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activity of angiotensinogen analog bearing a reduced peptide bond is due
to the change of a configuration at the scissile bond. The -CH2-NHmoiety is isosteric with the tetrahedral transition state formed during
amide hydrolysis and is therefore bound to the enzyme more tightly than
the substrate. It is further argued that because transition state
isosters bind to the enzyme so much more tightly, the effect of
structural variations present in substrates of different species is
magnified, resulting in the large difference in binding to human
compared with dog renin (Szelke n_ .sl....., 1982).
A potential transition state analog for serine proteases could
be designed by considering the charge distribution and stereochemistry
around C-1 of an inhibitor which should give a resemblance to the
proposed tetrahedral transition-state.

The peptide acids generated by

protease catalyzed hydrolysis of proteins are generally good inhibitors
of the enzyme that produced them, but the analog which mimics relevant
features of the transition state complex will form an even stronger
complex with the enzyme. A species I (fig-4) similar to transition state
in step-2 of fig-3, has been proposed by Jencks (1969) and Thompson
(1973) to be intermediate in the hydrolysis reaction catalyzed by
several proteolytic enzymes, e.g. the serine and cysteine proteases.
This suggests that the functional group which will provide tetrahedral
geometry and suitable charge distribution upon binding to the protease's
active site is expected to be a strong inhibitor for serine and cysteine
proteases.
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Figure-4. Tetrahedral intermediates of
serine and cysteine proteases.
(See text for detail)
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Transition

~

analogs

Q(

serine

~

cysteine proteases

Initially alkyl boronic acids, which readily form tetrahedral
addition compounds, Fig.
for

~,

were proposed as transition state analogs

chymotrypsin (Koehler and Lienhard, 1971). The use of boronic acid

group as an inhibitor, that binds strongly but yet could be removed
easily by a slight change in pH, was initiated by Berezin.
The tetrahedral intermediate will be highly unstable by virtue of
good leaving groups on the carbonyl carbon.

It will collapse easily to

give either the acyl enzyme or the substrate. In case of alkyl boronic
acid as a substrate, the ionized alkyl boronic acid (species II in fig4) will be relatively stable. The support to this argument comes from
the experimental observation that the benzene boronic acid (K 1 :1.96x10-~
M) associates stronger to chymotrypsin than to its substrate analog,
benzyl alcohol <Kr= 1.0x10-2 M). X-ray crystallography of benzene boronic
acid-subtilisin complex the showed formation of a tetrahedral structure
for benzene boronic acid, which formed a covalent bond between boron and
alcoholic oxygen of serine residue of subtilisin (Mathews, 1975).
Spectrophotometric determinations revealed a two step mechanism, in
which a fast bimolecular association process is followed by a slower
unimolecular isomerization process representing covalent bond formation
(Nakatani t l

.a.L_,

1977 ).

X-ray crystallography of the complex formed between subtilisin and
L-Phe-L-Ala-L-Lys chloromethyl ketone at 2.5 A0 showed that it also
formed a stable hemiacetal in which carbonyl carbon atom was
tetrahedrally coordinated (Poulous fi .al...., 1976; Robertus fi .al...., 1972).

31

0

x-ray investigation at 2.8A of the binding of papain to some peptide
chloromethyl ketone inhibitors, containing L-Phenylalanine at P2
provided informative structural data about enzyme substrate interaction.
Electron density difference maps of the papain-inhibitor complex
revealed that the carbonyl oxygen of the P1 residue is near two
potential hydrogen donating groups in the active site of the enzyme. The
carbonyl oxygen of the P1 residue, carrying a formal negative charge in
the tetrahedral intermediate, may be stabilized by formation of two
hydrogen bonds with the backbone NH of cysteine-25 and the NH2-group of
glutamine-19 (Drenth, 1976). Thus the

c1

carbonyl carbon of peptide

halomethyl ketones, upon associating with serine and cysteine proteases,
appears to assume a tetrahedral structure in its stable inhibitor
complex. Since these polypeptide halomethyl ketones inactivate serine
and cysteine proteases by alkylating an active site histidine, the
binding is irreversible and the utility of these inhibitors as ligands
in affinity chromatography for purification of proteases is nonpractical. This leaves alkyl boronic acids or peptide aldehydes as
possible alternatives for ligands in affinity chromatography.
It is clear that derivatives of peptide acids in which the
carboxylic acid group has been replaced by an aldehydic group are more
potent inhibitors of certain proteases than are the original acids. This
phenomenon was first discovered by Kawamura and Umezawa (1969) while
screening filtrates of Actinomycetes for naturally occurring protease
inhibitors. It was also independently discovered by Westerick and
Wolfenden (1972) and by Thompson (1973) in a search for transition state
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analogs for cysteine and serine proteases. Aldehydes are unique among
carbonyl carbon in preferring to exist as tetrahedral addition
complexes.

The hemiacetal (species III) is relatively stable. There are

clear analogies between the tetrahedral species I, II and IV.
Hemiacetals and hemithioacetals might therefore be expected to be good
transition state analogs for those proteases which react through a
tetrahedral intermediate or transition-state of general structure I.
These hemiacetals or hemithioacetals should be easily generated from the
corresponding aldehyde and the enzyme.
It is of interest to find out whether aldehydes are bound by
enzymes as covalent adducts or not. Alternatively inhibition could be by
a non-covalently associated aldehyde hydrate.

Using a cross-saturation

technique in nuclear magnetic resonance spectroscopy, Bendall

~ ~

(1977) provided the first direct evidence for formation of
hemithioacetal, formed from the aldehyde and the active-site thiol group
in papain. It was also shown that the aldehyde, and not the hydrated
form, is the true inhibitor. Lewis and Wolfenden (1977) made use of
effect of deuterium substitution on the equilibrium addition of
nucleophiles to aldehydes to discriminate between noncovalent and
covalent associations of aldehydes to papain.

The secondary isotope

effects on Ki can theoretically distinquish between covalent and
noncovalent binding of aldehyde. The results suggested a thiohemiacetal
is formed at the active site,

indicating a covalent binding.

Because of the strong nucleophilic character of the active site
serine residue in serine proteases, formation of a stable covalent

complex between the enzyme and the aldehyde was considered to be very
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likelY (Thompson, 1973). Since the formation of aldehyde hydrates and
hemiacetals are subject to general-base catalysis, the His-residue in
the active site may, a priori be expected to facilitate formation of
a hemiacetal by removal of a proton from the serine. Aldehydes exist
predominantly as hydrates in aqueous solution. The hydrates,

which are

gemdiols, can bind to proteases non-covalently. However, it was not
thought that the hydrate would have a high affinity even though they
present a tetrahedral

c1

carbon to the enzyme as Ac-Pro-Ala-Pro-Alaninal

binds 1000 times stronger than Ac-Pro-Ala-Pro-Alaninol to elastase at
pH-7.0 (Thompson, 1973). Since it was believed that the non-covalent
binding of the aldehyde hydrate could not strongly bind to elastase,
Thompson (1973) suggested that it is not the hydrate but the unhydrated
form of the aldehyde that binds to the enzyme.
Additional evidence to support binding of the free aldehyde and not
the hydrate also comes from NMR.

A plot of the corrected line-width of

the CH proton of the aldehyde and the hydrated aldehyde for the
chymotrypsin-inhibitor (Bz-Pheal)

rati~

at pD 6.5 showed that the

aldehyde and not the hydrated aldehyde is in equilibrium with the
inhibitor on the enzyme (Chen ~ ~ 1979). In 19F NMR spectra of DLAc-Pheal there are two signals assigned to the aldehyde. The smaller
signal at -37.6 ppm is assigned to the free aldehyde and the larger
signal at -38.4 ppm to the hydrate. Upon addition of chymotrypsin, two
new signals appeared at -33.8 and -37.1 ppm. The percentage of the total
19F signal area corresponding to the -33.8 ppm signal increases with
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increasing E/I ratios. Concomitantly the free aldehyde signal at -37.6
ppm decreases dramatically in intensity relative to the hydrate signal,
leading to the same conclusion reached before by Chen

~ ~

(Gorenstein

and Shah, 1982 ).
As the unhydrated aldehyde is the species that is primarily
associated, the true Kr for aldehyde association is equal to
Kr(obs)/(1+Kh), where Kh is the hydration association constant in water.
Although 1 M formaldehyde irreversibly denatures thrombin,

simple

aldehydes such as formaldehyde and acetaldehyde have no effect at
micromolar concentration. This suggests that the inhibition of peptidyl
aldehydes are unlikely to be a non-specific reaction of the aldehyde
with the enzyme (Westerik and Wolfenden, 1974).
The support for association for the aldehyde analog to chymotrypsin
as a hemiacetal (IIA or IIB in fig 2) comes from the observation of
association of aldehyde analog of the.nonspecific substrate
hydrocinamide to chymotrypsin by a cross-saturation NMR technique (Low
and Nurse, 1977). This was further supported by similar double resonance
experiments but with specific substrate analog, Bz-Pheal, with
chymotrypsin (Chen

~ ~

1979). The chemical shifts of hemiacetal are

most clearly defined under conditions of slow exchange on the NMR time
scale with the bound aldehyde (EI), which is known from the observed
line broadening to be in fast exchange with the free aldehyde. In the
case of the chymotrypsin and Ac-Pheal, maximum cross-saturation is
observed at the chemical shift of 5.36 ppm. This is the region in which
maximum cross-saturation is expected to be observed for the proton of
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the hemiacetal formed between the aldehyde and the active site serine
residue of chymotrypsin. The chemical shifts and signal line widths for
all protons of both Ac-Pheal and Bz-Pheal are essentially unaffected by
added (methyl-histidinyl-57)- chymotrypsin. The lack of clear evidences
for chemical exchange or cross-saturation in (methyl-histidinyl-57)chymotrypsin is due to tighter binding of aldehyde to the enzyme and
hence a slower dissociation rate which will fall within the NMR slow
exchange limit (Chen

~

.al.,., 1979).

Cross-saturation NMR studies of N-trifluoroacetyl-L-Ala-L-Pheal
with chymotrypsin showed broadening of free aldehyde resonance upon
addition of chymotrypsin (Gorenstein and Shah, 1982). The detailed
analysis identified the enzyme bound hemiacetal as the species which was
in slow exchange with the free aldehyde. From the line broadening
dependency

with pD, it is suggested that a single group on the free

enzyme (pKa=7.9) control the appearance of an alkaline form of the
hemiacetal (Wyeth

~ ~

1980). Fluorine NMR spectra of N-Ac-DL-p-

fluoro-Pheal in the presence of chymotrypsin showed separate signals for
the hemiacetal complex, the bound aldehyde along with the free aldehyde,
and the free hydrate (Gorenstein and Shah, 1982; Shah and Gorenstein,
1983).
The pH dependency of Ki(obs)

for Bz-Pheal binding to native

chymotrypsin between pH-3 and pH-8 exhibit a lack of a significant pHdependency. This lack of pH dependency suggests that the basic form of
charge relay system, which probably participates in the transition state
of substrate catalysis (Kraut, 1977), is not required for the high

3fi

affinity of the aldehyde Bz-Pheal to chymotrypsin. This result correlates
with the high affinity observed for Bz-Pheal to (methyl-histidinyl-57)chymotrypsin, in which the charge-relay system is modified by
methylation of His-57 instead of protonation at pH<7 (Kennedy and
Schultz, 1979). Chen

~

.sL.. (1979) also found a poor affinity between

Bz-Pheal and (dehydroalaninyl-195)-chymotrypsin by proflavin
displacement. This is because of the lack of ability of Ser-195 to form
covalent hemiacetal adduct between Bz-Pheal and Ser-195. In addition
the observation that the alcohol derivative (Bz-Pheol), which contains
an sp3 configuration about its C-1 carbon and thus can only associate
non-covalently, does not have a high affinity to native chymotrypsin
suggests the formation of a covalent hemiacetal adduct for the tightly
bound aldehyde (Kennedy and Schultz, 1979).
A reasonable explanation of the pH independence of Ki(obs) for BzPheal association is that a two proton transfer occurs on Bz-Pheal
association leading to the protonated tetrahedral complex IIB (Fig.2)
as the major association species, rather than the anion species IIA. The
simplest form of reaction sequence between an aldehyde and a serine
protease could be depicted as in equation 5.

E + Aldehyde(unhydrated)

k_,

IA

IIA and or IIB •••• (5)

where IA, IIA and IIB are species shown in fig-2. Step k2 may be
depicted as a two step proton transfer process in which the His-57
imidazole first abstracts the proton from the r-0 of serine-195

generating the

Y-o-

nucleophile, and in a second step the solution
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donates a proton to the oxygen anion on C-1 of the aldehyde resulting in
the capture of the stable neutral tetrahedral adduct IIB. As the reverse
reaction would be specific base-general acid catalysis and it is
kinetically indistinguishable from general base catalysis, both k2 and
k_ 2 have the formate kx

= k(lim)/(1+~/Ka).

The denominator term cancels

out in the ratio k2/k_ 2 and thus KI(obs) shows no dependency on
hydrogen ion concentration. The small variation in KI(obs) with pH may
be simply due to small increases in Ks with decreasing pH.
Alternatively, a two proton transfer can occur in a concerted
rather than in a stepwise fashion. In a concerted process the His-57 in
step k2 acts both to abstract the -OH proton from the serine and
simultaneously donate that proton to the developing oxygen anion of
incipient IIA, generating IIB in a single step. In any case, both steps
k2 and k_ 2 require the basic form of the His-57, and the ratio k2/k_ 2
and thus KI(obs) show no clear pH dependency (Kennedy and Schultz,
1979).
James

~ ~

(1980) described a structure of the microbial enzyme

Streptomyces griseus protease-A in its native conformation at 1.8 A0 ,
and in complexes with Ac-Pro-Ala-Pro-Phe-OH, Ac-Pro-Ala-Pro-Try-OH and
Ac-Pro-Ala-Pro-Pheal, at pH 4.1. The resultant electron density maps
showed that the peptide aldehyde forms a covalent hemiacetal bond with
Ser-195. The distance from the carbonyl carbon of the aldehyde to the l(0 of Ser-195 being 1.73 A0 • The corresponding distances in the proteasepeptide complexes are 2.58 A0 and 2.66 °A, and continuous electron

density from

d(-o
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to the carbonyl carbon atom of the peptides is absent.

Papain, a cysteine protease has similarities in mechanism to serine
proteases in association of peptide aldehydes. Aldehydes, structurally
related to the acyl portion of the substrates, are extremely potent
competitive inhibitors of papain at pH- 5.5 and 25° C, approximately 1
mole of acetyl-L-phenylalanyl amino acetaldehyde binds per mole of
papain, with Ki:4.6*1o- 8M (Westerik and Wolfenden, 1972). Also it is
shown that aldehydes protect the enzyme against inactivation by Nethylmalemide.

It is clear that the aldehydes form stable

thiohemiacetals which are similar to the hemiacetals formed in serine
proteases.
Thus the reaction of aldehydes with papain occurs in two steps as
shown in equation 6 (Mattis rt .ala., 1977),

E+ A

EA'

••••••••• ( 6)

where EA is the Michaelis complex and EA' is suggested to be a covalent,
tetrahedral hemithioacetal with the cysteine-25 sulfhydryl. Frankfater
and Kuppy (1981) studied the association of Ac-Phe-Glycinal with papain
in the pH range 3.5-9.5 at 25° C using intrinsic papain fluorescence to
measure aldehyde binding. The limiting values of Ki and the second
order association rate constant k2/Ks, corrected for hydration of AcPhe-Glycinal in solution, are 9.05x1o-1° Hand 4.95x107 H-1s-1,
respectively. The solvent deuterium isotope effect on the rate of
association is 0.77, indicative of the participation of the thiolate-
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imidazolium ion pair. The mechanism of aldehyde association shown in
fig. 5 with papain is proposed. Since it is likely the structure IV is
the predominant form of the hemiacetal in solution, a proton transfer
must occur in subsequent steps following formation of the Michaelis
complex. The value of <3 for the pKa of His-159 in papain-aldehyde
adduct may reflect a direct interaction between the N-1 of His-159 and
the hydroxyl group of the hemithioacetal. It is argued that the
hemithioacetal may be about 103 times more stable in papain than in
solution.

The wide range and diagnostic power of 13c NMR made possible

signal assignments for the aldehyde inhibitor-papain complex. Two
distinct hemithioacetal forms were observed which can be titrated
separately, one of which is more stable than the other at pH 7.0. They
appear to be equal amounts of both distereoisomers formed by the
creation of the new assymetric carbon generated on hemithioacetal
formation.

One diastereoisomer bound in a nonproductive mode is in

rapid equilibrium with the Michaelis complex (ES) while the other
distereoisomer in a productive mode is in slow equilibrium with the
Michaelis complex (ES) (see Fig. 6) (Gamcsik .tl £1.....,, 1983).
Thus the formation of a covalent hemiacetal or hemithioacetal
adduct between a peptide aldehyde and serine or cysteine protease is
supported by various techniques such as stopped-flow spectrophotometry,
proton NMR, 13c NMR, fluorine NMR, and X-ray crystallography.

2DL Peptide aldehydes

~

inhibitors Q( proteases

As it was noted previously, Umezawa initiated the study of peptide
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aldehydes produced by microorganisms as inhibitors of protease enzymes
in 1965. Since than nearly 50 inhibitors of various mammalian enzymes
have been identified in microbial culture filtrates. Their structures
have been elucidated and most of them have been chemically synthesized
(Umezawa, 1982). Leupeptin, which inhibited plasmin, trypsin, pepsin and
cathepsin B, was discovered by testing for plasmin inhibiting activity
in Streptomyces culture filtrates (Aoyagi

~ ~

1969). Two leupeptins

were isolated, and their structures were determined to be acetyl or
propionyl-L-Leu-L-Leu-L-Argal (Kawamura

~ ~

1969). Later a number of

other leupeptins were identified which contained L-Ile or L-Val instead
of L-Leu. NMR studies of leupeptins in aqueous solution indicates that
most of leupeptin exists as the hydrated and the hydroxypiperidine forms
(Maeda~~

1971; Schultz and Kozlowski, unpublished data). While

leupeptin inhibits trypsin like proteases, it does not inhibit
chymotrypsin. The aldehyde group in the argininal moiety is an absolute
requirement for inhibiting activity. If it is oxidized to acid or
reduced to alcohol, the compound's inhibitory activity disappears.
Along with leupeptins other important peptide aldehydes of the
microbial origin are antipain, chymostatin and elastinal. Fig 7 shows
the chemical structures of these inhibitors. Antipain inhibits papain,
trypsin, cathepsin B; chymostatin inhibits chymotrypsin like proteases;
and elastinal inhibits pancreatic elastase. Table 5 shows the inhibition
constants of leupeptin, elastinal and pepstatin against trypsin,
elastase and pepsin, respectively. The biosynthetic pathway of the
leupeptins have been elucidated from Actinomycetes and the three
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Figure 7. Cheffi cal structures of protease-inhibitors
of m crobial origin.

Table 6
Kinetic constants of endopeptidase inhibitors

-----Inhibitor

Enzyme

Substrate

~

Kr

(x10lJ M) (x107 M)
Leupeptin

Trypsin

Type of
inhibition

TAME

7.1

3.lJ

Competitive

BAEE

4.8

1.3

Competitive

Elastinal

Elastase

Ac-(Ala)~NA

3.2

2.4

Competitive

Peps tat in

Pepsin

Phe-Gly-His-Phe
(N02 )-Phe-Ala
Phe-ME

0.4

0.001

Competitive

Umezawa

~

Ql., (1983).
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important enzymes of the pathway have been isolated. These enzymes are
leucine acetyl transferase, leupeptin acid synthetase, and leupeptin
acid reductase. The membrane bound leupeptin acid reductase requires ATP
and NADH (Umezawa, 1983).
Even though the physiological function of leupeptins and other
inhibitors of microbial origin is not clearly known, the possible use of
these inhibitors as therapeutic agents has received considerable
attention. In addition, these enzyme inhibitors could be useful in the
analysis of biological functions and disease processes. Biological
activities of leupeptins have been investigated by Aoyagi

~ ~

(1969). Oral administration of leupeptin exhibited an anti-inflammatory
effect in edema. Leupeptin also inhibited coagulation in humans and
rabbits, but not in dogs and rats. These inhibitors are relatively non
toxic (Libby and Goldberg, 1978; Sher

~ ~

1981). Intra-venous

injection of 250 mg/kg and intraperitoneal injection of 1000 mg/kg of
antipain caused no deaths in mice. In the case of leupeptin, HD50 to
rats and rabbits are as follows: rats 125 mg/kg by intravenous
injection, >4000 mg/kg by subcutaneous injection and oral
administration; rabbits 35mg/kg by intravenous injection, 300mg/kg
subcutaneous injections, >1500 mg/kg by oral administration (Aoyagi
~

~

1969). The use of leupeptin as possible therapeutic agent in

muscular dystrophy, cancer metastasis and number of other diseases have
been investigated in animal models (Umezawa,1983; Umezawa,1979). The
exceptionally good inhibition constants of these microbial peptide
inhibitors have generated a good amount of interest for use in the
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inhibition of the important physiological proteases.
Specificity toward a particular enzyme may be obtained by varying
amino acid sequence in P2 , P3 and P4 position of inhibitors in a Cterminal aldehydic peptide similar in structure to the naturally
occurring peptide aldehydes. A number of peptide aldehydes targeted
toward specific enzymes have been synthesized and tested for their
inhibitory properties. Galpin

~ ~

(1984) synthesized protease

inhibitors with the general structure Z-Arg-X-Pheal where X= Leu, Ile or
Val. These compounds showed strong inhibitory activity towards
chymotrypsin whereas the semicarbazide derivatives of the compounds and
showed considerably reduced activity. Renin catalyzes hydrolytic release
of angiotensin I from the N-terminal end of angiotensinogen. From prior
knowledge of the amino acid sequence around the scissile bond in
Szelke's (1982) experiments on angiotensinogen, Kokub

~ ~

(1984)

postulated that small peptides of the angiotensin I sequence with
leucinal at its C-terminal might inhibit renin. Three different
compounds were synthesized and the results obtained show that these
aldehyde compounds are highly selective and species specific inhibitors
for human and monkey renins. Fehrenz

~ ~

(1984) synthesized a series

of tripeptide aldehydes of the type P-A-Y-Xal where P is aoC-NH2
protecting group, A is an aromatic residue, Xal is either leucinal or
phenylalaninal and Y is a variable residue. The result showed that these
peptide aldehydes are also very specific and potent inhibitors of renin.
Acrosin is an important intracellular endopeptidase of spermatozoa
that is exposed to the cell surface at the time of gamete fusion. The
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proteinase assists the penetration of spermatozoon through the outer
investment of the ovum by proteolytic degradation of the zona pellucida,

a glycoprotein layer surrounding the oocyte. The presence of natural and
synthetic acrosin inhibitors effectively prevents zona penetration and
hence fertilization in yitro and in YiYQ (McRorie and Williams, 1974).
consequently, synthesis of acrosin directed inhibitors is highly
desirable in view of their potential contraceptive action. Khatri and
stammer (1980) synthesized small N-phosphorylated peptide aldehydes
analogous to both leupeptin and phosphoramidon. As phosphoramiradon is
an inhibitor of acrolysin, combination of these two structures in to one
molecule produced a compound inhibitory to both the enzymes. Borin
~

~

(1981) synthesized a series of leupeptin analogs R-Lel-Leu-

Argininal with variable N-terminal substituents. These modified
leupeptins proved to be strong competitive inhibitors of the acrosin
from mammalian spermatozoa with inhibition constants in the range of
4.7x1o-7M (R=H) to 9.7x1o-7M (R=t-Boc). Preliminary data in this study
indicated that Boc-leupeptin and F3Ac-Leupeptin derivatives do not
exhibit higher toxicity than the leupeptin.
Specific peptide aldehyde inhibitors have been targeted for a
number of enzymes involved in coagulation and fibrinolytic processes. In
case of thrombin, the structure of these inhibitors correspond to the
thrombin sensitive region of its clotting factor substrates. Bajusz

~

al. (1978) synthesized a series of tripeptide aldehydes, X-Pro-Argal and
X-Val-Argal. The molecular excess of inhibitors to enzyme required for
doubling the clotting time of fibrinogen in plasma was found to range
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over five orders of magnitudes, 6.3 times for D-Phe-Pro-Argal to 45950
times for Gly-Val-Argal. From this observation of D-Phe-Pro-Argal being
a potent inhibitor of thrombin, Tremoli

~ ~

(1981,1984) showed that

it significantly prolonged the human whole blood recalcification time in
~and

inxiYQ, as well as plasma thrombin, partial thromboplastin

and prothrombin times. In vivo experiments showed a 90% reduction in
experimental thrombosis in rats at 6mglkg intravenous administration. A
comparison of the inhibiting activity of Boc-0-Phe-Pro-Argal and D-PhePro-Argal towards thrombin and plasmin indicates that the Bocderivative inhibits both plasmin and thrombin while the free peptide
aldehyde has practically no effect on plasmin (Bajusz
~

~ ~

1981).

Affinity chromatography
Thirty years after its introduction (Lerman, 1953), affinity

chromatography. (a method of purification based on affinity between two
molecules) has become a major means for the purification of biologically
active molecules. The purification of proteins by conventional
procedures is frequently laborious and incomplete, and the yield are
often low. Enzyme purification based on a highly specific biological
property - strong reversible association with specific substrates or
inhibitors - has received major attention (Cuatrecasa, Wilchek and
Anfinsen, 1968). Despite the enormous expansion of the field and many
enzymes that have been purified, the directions for the investigation of
methods have not changed markedley. The component attached to the solid
matrix support is called a ligand. The attachment may be made by

49

physical adsorption or by a covalent bond. The covalent attachment is
rar superior and should be used whenever possible to prevent leakage of
the ligands. In affinity chromatography of an enzyme, the enzyme to be
purified is passed through a column containing a crossed linked polymer
or gel to which a specific inhibitor, cofactor, substrate analog or an
antibody specific to the enzyme has been covalently attached. All
proteins, without substantial affinity for the bond ligand will pass
directly through the column, where as the enzyme that recognizes the
ligand will be retarded or stay bound, depending upon its affinity
constant. Elution of the bound enzyme is readily achieved by changing
such parameters as ionic strength, pH or by addition of a competitive
inhibitor in the eluting solution. In this dissertation we introduce
additional method for removing a bound enzyme by reversible chemical
modification of the ligand thereby, effectively reducing the
concentration of active ligand (Patel and Schultz,1982;

Patel~~

1983).
The success of the technique depends largely on mimicking the
interaction between the two components that occurs when both compounds
are in free solution. The successful application of the method requires
that the adsorbent have a number of favourable characteristics. The
unsubstituted matrix or gel should show minimal interaction with
proteins, in general, both before and after coupling to the specific
binding groups. It also must form a loose, porous network that permit
easy entry and exit of macromolecules and have favourable flow
properties. The chemical structure of the support must permit the
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convenient and extensive attachment of ligands under relatively mild
conditions, and through chemical bonds that are stable to the conditions
of adsorption and elution. Finally, the ligand which is critical in the
interaction must be sufficiently distant from the solid matrix to
minimize steric interference with the binding process. This could be
achieved through a spacer arm between ligand and matrix.
Enzymes represent the largest group of macromolecules purified by
affinity chromatography. The purification of enzymes by affinity
chromatography can be divided mainly in to three categories. The first
category includes ligands designed for the purification of a wide range
of enzymes by using general ligands like cofactors. The most commonly
used cofactors are NAD, NADH, ATP and Co-A or their derivatives. The
second category includes ligands directed at enzymes of narrow
specificity, i.e. enzymes purified with the aid of specific inhibitors
or substrates. In this case the specificity is much higher for the
enzyme for which the column was tailored. At times, specific columns
serve also for the purification of a family of enzymes having similar
specificity. e.g. benzamidine-Sepharose for trypsin like proteases. The
third category includes ligands designed on a knowledge of a part of the
three dimensional structure of the enzyme to be purified. For this
method either polyclonal or monoclonal antibodies are used as ligands.
Unless there is cross-reactivity, these affinity resins are highly
selective for a particular enzyme. In any case the degree of
complementarity between interacting molecular surfaces or regions of the
constituents of a complex determines the magnitude of attraction, and
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thus the strength of a complex.
An agarose is the predominant choice as an innert matrix in
affinity chromatography of enzymes, and cyanogen bromide as an
activating agent. Fig 8 shows mechanism of activation of Sepharose by
cNBr and subsequent coupling of the ligand. Detailed analytical data of
freshly activated Sepharose showed that 60-85% of the resins total
coupling capacity is due to the formation of the cyanate esters (cyanate
ester 80%, imidocarbamates 20%) (Kohn, 1981). Once the mechanism of
activation was established, it opened up new ways to develop more
efficient activation procedures and these are extensively reviewed by
Wilcheck

~ ~

(1984). Among these, organic sulfonyl chlorides provide

a coupling procedure which give a high yield of stable linkages at
neutral pH. Organic sulfonyl chlorides such as p-toluene sulfonyl
chloride (tosyl chloride) and 2,2,2-trifluoroethane sulfonyl chloride
(tresyl chloride), can be used to convert hydroxy groups into good
leaving group (sulfonates) that, on reaction with nucleophiles, allow
stable linkages to be formed between the nucleophile and the initial
hydroxyl group carrying carbon. These reagents appear to be suitable for
the immobilization of enzymes and affinity ligands to support bearing a
hydroxyl group, such as agarose, cellulose, glycophase glass and others.
The activation and coupling of the ligands to the support are though to
involve the following steps (Nilsson and Mosbach, 1984).
Activation:
Support-CH20H + RS02Cl
Coupling: e.g. NH2- nucleophile

0

hydrolysis

CNBr

---)~
H

~0-C::N

n

~O-C-NH2 CARBAMATE (inert)
NH
~

o.j
rearrangement ~0-Cinterchain

CYNATE ESTER
(very reactive)
intrachain

~

c-NH

rearrangement

ISOUREA
DERIVATIVE

N-SUBSTrnrrED

IMIOOCARBAMATE

LINEAR
IMIOOCARBAMATE
(very slightly reactive)

CYCLIC
IMIOOCARBAMATE
(slightly reactive)

N-SUBSTITUTED

CARBAMATE

Figure-8. Mechanism of activation of Sepharose by CNBr and
subsequent coupling of ligand. Heavy lines indicate
major reactton pathways.
(WUchek .tl.

.al_. , 1981!)

53
--~>

Support-CH2-NH-ligand.

The influence of R group on the relative reactivity of sulfonates with
organic molecules containing hydroxyl groups was found to be 1:100:4000
with R= -C6H4CH3, -CH2cF 3 and -CF 3 respectively. Thiols and primary
amino groups are the most reactive nucleophiles with sulfonate esters on
gels. Thiols have the highest reactivity. Imidazole and tyrosine
hydroxyl groups can also displace the esters. This broad range of
reactive nucleophiles can be a great advantage when a very tight binding
between protein and support is desire, i.e. for stabilization or
freezing of the protein conformation.
Among the synthetic carriers, hydrophylic cross-linked polyacrylic
polymers are of great interest. The distinct advantages of these
polymers are the far superior mechanical stability compared to agaroses
and their innertness to microbial degradation. In addition they have a
higher stability towards acids, bases and organic solvents. The degree
of porosity and chemical composition can be achieved by selective copolymerization or by chemical modification of preformed polymers.
Various synthetic polymers based on acryamide or acrylate and their use
to immobilize enzymes have been reviewed by Mosbach (1977).
Certain amino acid residues in proteins are amenable to covalent
.. reaction for immobilization of proteins or peptides on innert supports.
Table 7 shows eleven amino acids whose residues could be considered
reactive enough to participate in covalent coupling to a carrier. Of the
amino acids listed in Table 7, the most frequently used functional
groups are -NH2 , -SH and -COOH.
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Table 7

Reactive residues of proteins

-~

-Amino of Lysine and H-terminus amino group

-SH

Sulfhydryl of cysteine

-COOH

Carboxyl of Aspartate and Glutamate
and C-terminus carboxyl groups
Phenolic of Tyrosine

Guanidine of Arginine

Imidazole of Histidine

-S-S-

Disulfide of Cysteine

Indole of Tryptophan
Thioether of Methionine
Hydroxyl of Serine and Threonine
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The most widely used procedure for covalent coupling of proteins to

a support has been the one devised by Ax en ll. .al....., ( 1967). The
polysaccharide (Sepharose) is activated with cyanogen bromide and the
activated sepharose is coupled to an amino group on the protein to yield
the immobilized product. Currently a number of sepharose derivatives
with desired spacer arm and appropriate functional group to covalently
bind to specific ligands are commercially available. The spacer arms
ranges from four carbon atom to fifteen carbon atoms long, predominantly
either with amino or carboxylic terminal. The reactive derivatives of
spacer arm equipped sepharoses are also commercially available. Among
these derivatives, N-hydroxy succinamide ester activated sepharoses are
very useful for rapid, high efficiency coupling for all ligands that
have a primary amino group.
Affigel-10 and Affigel-15 (Bio Rad) are N-hydroxy succinimide
esters of a derivatized cross-linked beaded agarose gel support. Both
couple to ligands containing primary amino group spontaneously in
aqueous or non-aqueous solutions. Figure 9 shows the chemical structures
of Affigel-10, Affigel-15, and the coupling reaction of the Affigels
with the ligand containing a free amino groups. Affigel-10, which
contains a neutral 10-atom spacer arm, has been used to couple a wide
. variety of ligands in affinity chromatography. Affigel-15 contains a
cationic charge in its 15 atom spacer arm, which significantly enhances
coupling efficiency for acidic proteins at physiological pH. The Nhydroxy succinamide active ester method is highly selective for primary
amino groups of ligands between pH-6.5 to 8.5. Proteins can be coupled
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Affi-Gel 10

Affi-Gel 15

1

LJLR-~ _P_H_6_.5_to_a_.5~

r

~

buffer

Figure-9. Coupling reaction of Affi-Gels 10 and 15 with
ligand containing free amino groups.
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within four hours at 4°C. Since the coupling is through an amide bond
and the spacer arm is linked through an ether bound to the matrix, an
excellent resistance to urea, guanidine.HCl, heat, solvents, acids and
bases (pH 2 to 11) virtually eliminates ligand leakage during storage
and use (Conn

~ ~

1981). Both Affigel-10 and Affigel-15 are used

during this investigation to prepare affinity resins. The exact coupling
strategy and conditions will be discussed in a later section.
Initially lysine and benzamidine sepharose affinity resins were
prepared for purification of trypsin like proteases. A typical procedure
involved activation of sepharose with CNBr and coupling of either lysine
or p-amino benzamidine with or without a spacer arm (Hatton and
Recoeczi, 1976). The solution containing enzyme is charged onto a column
of benzamidine Sepharose in low ionic strength (50 mM NaCl buffer) and
subsequently washed with higher ionic strength NaCl-buffer in order to
wash off nonspecifically bound proteins. Elution of the enzyme is done
under competitive conditions, i.e. the eluent contains either p-amino
benzamidine or other protease inhibitor (Anderson

~ ~

1977).

In affinity chromatography of trypsin like proteases, the
positively charged aminidinium or guanidinium group is required for
primary specificity. These groups must be excluded from the covalent
bonding of ligand to matrix.

In the case of peptidyl aldehydes as

ligands, the aldehydic group is also essential for the formation of a
reversible covalent bond with the protease. This leaves only the NterminaloC-NH2 group for covalent bonding with the matrix. Since the Nterminalc(-amino group is acetylated by either acetyl or propionyl group

58
in the leupeptins, in order to use leupeptin as a ligand for affinity
adsorbents, appropriate modification is required. Ishii and Kasai (1980)
used thermolysin to hydrolyze the bond between two leucines in leupeptin
to expose

an~amino

group. Figure 10 shows the outlines of the

preparation of the affinity resin. The aldehyde group was protected as
dibutyl acetal and deprotected after immobilization. As expected, these
affinity resins showed strong affinity for trypsin-like proteases. In
addition, the resins completely lost their binding ability, if the
aldehyde group was converted to the corresponding alcohol by treatment
with NaBH4• The argininal resin bound enzymes like Streptomyces griseus
trypsin, plasmin, kallikrein, urokinase and clostripain. Ishii could not
elute the enzymes by the conventional methods, such as by an elevation
of ionic strength, lowering of pH, or addition of denaturents.
Successful elution was achieved only by the addition of 0.02 mM
leupeptin to the eluting buffer at very slow rate, after incubating
overnight. The eluted enzyme was not active because it was complexed
with leupeptin and the activity was only restored after inactivating
leupeptin by NaBH4 (2mM). To regain enzyme activity it was important
that the enzyme tolerate such reductive treatment. Nishikata

~ ~

(1981) prepared Sepharose-Gly-Gly-Argal, and showed it to be a strong
affinity resin for bovine trypsin. The enzyme was eluted with 8 M urea
or 1mM leupeptin in buffer at a flow rate of 6 ml/hr. While tosyl-lysine
chloromethyl ketone-trypsin and (dehydroalanine-195)-trypsin failed to
bind the resin, carbamoyl methylated (His-46) trypsin bound to the resin
and could be eluted with 50mM HC1/1M NaCl.
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Leupeptin (I)

1-BuOH
R2

1
.))Bu
R1-Leu-Leu-NH-CH-CH
Leupeptin dibutylacetal

'oau

Thermolysin
R

12

/OBu

H-Leu-NH-CH-CH 'OBu

Leucylargininal
dibutyl acetal

Illloobilization
R

12

Leu-NH-CH-CH~

R

12

Leu-NH-CH-C~

OBu
OBu

Immobilized leucylargininal
dibutylacetal

H

~0

Immobilized leucylargininal

Figure-10. Preparation of affinity resin using
Leu-Argininal as ligand.
Ishii~

.a.J..., (1980).
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Anderson and Wolfenden (1980) have described a technique they named

"transition state affinity jump" chromatography. In this procedure, a
double selection method for isolation of active enzyme, a substrate
analog is used as a ligand and a transition- state analog is placed in
the solution of eluent. Thus a mixture of native chymotrypsin and
dehydroalanine-(195)-chymotrypsin was applied to a column containing Dtryptophan methyl ester as an affinity ligand. While both forms of
chymotrypsin were retained, catalytically active enzyme selectively
eluted with the peptide aldehyde chymostatin leaving catalytically
inactive dehydroalanine-chymotrypsin bound to the column.
Nishikata (1983) also prepared an affinity resin using Gly-GlyPheal which is a synthetic analog of chymostatin as a transition -state
analog for chymotrypsin. Bovine chymotrypsin and Streptomyces griseus
protease B showed strong affinity toward the adsorbent. The dissociation
constant, Kd, of the enzyme-immobilized ligand complexes were determined
by frontal gel chromatography. The value of dissociation constants
varied from 13x10-6M at pH-6.5 to 1.7x10-6M at pH-8.2 for chymotrypsin.
The author tried to validate the results by comparing the dissociation
constant obtained with Ac-Val-Val-Pheal at pH 7.7 (3.8x10-6M), and that
of Ac-Pro-Ala-Pro-Pheal to be 3x1o-6 M at pH-8.0, with the argument that
Ac-Val-Val-Pheal and the ligand Gly-Gly-Pheal have similar structures.
The difference in size and hydrophobic nature of side chains of glycine
and valine should be pointed out here, and it could be very significant
in terms of interaction with the enzyme in s2 and

s3

subsites.

Proposed transition state analogs other than peptide aldehydes also
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have been used as affinity ligands. Pohl

~ ~

(1984) used Val-D-Leu-

Pro-Phe-Phe-Val-0-Leu as an affinity ligand, which is a transition-state
analog inhibitor of aspartate proteinases of the pepsin type. The
affinity adsorbent bound human, porcine and chicken pepsin, human
gastrin and bovine cathepsin D over the pH range 2 to 5. The elution of
enzyme was achieved by a low ionic strength buffer at higher pH
containing 20% dioxane, in yields exceeding 70%. The resin however,
failed to separate human pepsin from human gastrin. A more specific
inhibitor like H-77 (0-His-Pro-Phe-His-Leu-R- Leu-Val-Tyr, where R is a
reduced isosteric bond -CH2-NH-) of acid-proteases, was used as ligand
for purification of human kidney renin by Mcintire

~ ~

(1983). With

this affinity adsorbent, human renin was isolated from crude extract of
kidney cortex with 5500 fold purification and 76% yield. The purified
enzyme was free of non-specific acid-proteases and was stable at pH 6.8
and -20°C over a period of several weeks.

~

Plasminogen activator
The examples of plasminogen activator and thrombin are selected in

this dissertation to develop affinity adsorbents. Both of these enzymes
are trypsin-like proteases and have important roles in fibrinolytic and
coagulation processes. Both plasminogen activator and thrombin resemble
trypsin and plasmin in their activities towards synthetic substrates,
but there are differences in their relative activities which depend upon
the particular substrate on which they act (Table 4). However,
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plasminogen activator and thrombin are much more selective in their
specificity toward proteins. There are several different types of
plasminogen activators, including tissue activator of plasminogen,
vascular plasminogen activator, blood plasminogen activator and
urokinase. Tissue activator of plasminogen may be identical or similar
to blood plasminogen activator, but different from urokinase which is
isolated from urine or kidney cell cultures. Tissue plasminogen
activators are serine proteases with a molecular weight of approximately
66,000 and composed of one polypeptide chain. By limited proteolytic
action, this one-chain activator is converted in to a two-chain
activator linked by disulfide bonds. Both the one chain and two chain
plasminogen activator have similar activity in clot lysing systems, but
different specificities toward synthetic substrates (Wallen

~ ~

1981). Urinary plasminogen activator was described in 1951 by Williams
and in the following year was named urokinase. There are two forms of
urokinase, one with Mw=54,000 and a smaller form with Mw=34,000. Both
high and low molecular weight urokinase behave similarly in an in vitro
whole blood thrombolytic perfusion system (Greenwald and Chandler,
1983). It has been shown that urokinase is much more selective than
plasmin in its action on proteins, plasminogen being the only substrate
against which urokinase shows activity. Robins

~ ~

(1967) showed

that during the activation of plasminogen to plasmin, a single bond
Arg560_Val561 is cleaved by urokinase.
The mechanism of proteolysis of a single-chain plasminogen molecule
to two-chain disulfide-linked plasmin molecule by urokinase is by the

~3

following steps (Violand and Castellino, 1976; Summaria

~ ~

1975).

In the first step urokinase catalyzes cleavage of Arg65°-Val561 peptide
bond forming two chains linked through a disulfide bond. In the second
step the Lys7 6-Lys77 peptide bond is hydrolyzed by autolytic cleavage.
With this hydrolysis, a whole 1 to 77 N-terminal peptide is removed. The
resultant plasmin molecule with Mw=75,000 to 81,000 (Robbins and
summaria, 1976), has a broad trypsin-like specificity towards proteins.
In normal cells plasminogen activator synthesis can be modulated by
physiological concentrations of hormones or other biologically active
compounds (Reich, 1978; Weinstein, 1978). Transformation to neoplastic
cells may be correlated with increased plasminogen activator synthesis.
This circumstantial association has been explored by the researchers who
are interested in the biology of the malignant cells.

Most studies

indicate increased synthesis of plasminogen activator in malignant cells
compared to normal controls. Because of plasminogen activator's
association with neoplasia, important purification techniques from
culture media will be reviewed.
Goldfarb and Quigley (1980) isolated plasminogen activator
(urokinase) from culture supernatents of Rous sarcoma virus transformed
chick embryo fibroblasts treated with the tumor promoter phorbol-12myristate-13-acetate (PMA) by multiple affinity chromatography.
Plasminogen activator was adsorbed on to p-aminobenzamidine-CH
•

Sepharose-B at pH 7.0. Following adsorption the resin was washed with
buffer containing Triton X-100. The enzyme was eluted with buffer
containing 0.5 M benzamidine at pH 4.0. All the fractions were dialyzed
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to remove benzamidine and the fractions containing enzyme were pooled
and re-adsorbed on benzamidine adsorbent at pH 7.0. The enzyme was
eluted and fractions were dialyzed to remove benzamidine as previously
described. Active fractions, partially purified and concentrated by two
rounds of affinity chromatography were subjected to a molecular sieving
gel (G-100 Sephadex) at 4°C. Plasminogen activator containing fractions
from gel-filtration were dialyzed and applied to cation exchange resin
(sulfopropyl-Sephadex C-25) at 4°C. The enzyme was eluted by stepwise
increase of ammonium sulfate concentration and each fraction was assayed
for protein and enzyme concentration. The final yield of enzyme was 43%.
The enzyme activity profile demonstrated a major plasminogen activator
activity of 46,000-48,000 daltons and a minor activity of 23,000-26,000
daltons.
Dano .tl. .a.J......, ( 1980) and Maroti .tl. .a.J......, ( 1982) also reported
purification procedure of plasminogen activator from mouse cells
transformed by an oncogenic viruses using an affinity adsorbent
containing p-aminobenzamidine as the ligand. In the procedure, serum
free media was brought to pH 5.5 and passed over p-aminobenzamidineaminocaproyl-Sepharose. After washing the column with 0.5 M NaCl, the
proteins were eluted with buffer containing 0.9 M benzamidine at pH 7.4.
The benzamidine was removed by dialysis against 10 mM Tris-HCl, and pH
7.4/1 mM zinc acetate. The proteins were recovered as precipitates by
centrifugation at 12,000xg for 30 min. The proteins were extracted into
100 mM glycine-HCl, pH 2.2/1 mM zinc acetate. The clear solution was put
over a QAE-Sephadex A-50 column to further purify. The fractions
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containing enzyme activity were subjected to preparative gel
electrophoresis followed by elution with buffer and then dialysis. These
types of procedures are laborious and low yielding.
Since benzamidine-Sepharose affinity is a general purpose affinity
adsorbent for trypsin-like proteases, more specific systems for
purification of urokinase were exploited using one of the properties of
urokinase, which is to bind to the fibrin clot. The gel-like consistency
of fibrin is not practical for the purpose of purification, but fibrin
deposited on celite was found suitable for affinity chromatography
(Husain

~ ~

1981). The procedure involves adsorption of vascular

plasminogen activator from plasma onto a fibrinlcelite matrix, and the
elution of plasminogen activator with a buffer containing 0.2 M
arginine. The fractions containing active protease were subject to gelfiltration through a Sephadex G-100 column. This high fibrin affinity
plasminogen activator had a low specific activity of 500 U/mg protein,
compared to tissue or urine plasminogen activators (100,000 to 200,000
U/mg).
Immunological reactivity is highly specific and the binding
constants are very high between antigen and antibody. Wallen

~ ~

(1983) reported a three step purification procedure combining the
principles of immunospecificity, affinity for arginine and gelfiltration,in the purification of melanoma cell tissue type plasminogen
activator. The first step was the adsorption onto an antibody-resin. The
second step involved chromatography over arginine-sepharose. The third
step was a gel-filtration on Sephadex G-150. The enzyme was eluted off
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the antibody column with a strong denaturant, 3M KSCN, guanidinium
chloride (0.3 M).
A slight variation of the same procedure was utilized by Booyse

~

il· (1984) in the purification of urokinase type plasminogen activator
from cultured human endothelial cells. In their procedure, the enzyme
was isolated first by p-aminobenzamidine agarose affinity chromatography
followed by gel-filtration on Sephacryl-200. The final step involved
adsorption on anti-urokinase IgG-Sepharose CL-4B. The elution of the
enzyme was accomplished with 4 M Guanidine-HCl at pH 6.5 buffer
containing Triton X-100. The overall yield was 49.6% with specific
activity 94,000 U/mg protein.
Proteases are commonly synthesized in inactive proenzyme forms
are activated by a modulator or by another protease. Anderson

and

~ ~

(1984) showed that tissue-type plasminogen activator from human melanoma
cells is synthesized in an inactive proenzyme form with a single chain
(Mw-66,000). A single step purification procedure using monoclonal
antibody affinity resin is described. Salerno

~ ~

(1984) reported

the identification of the single-chain prourokinase precursor with
monoclonal antibodies from rabbit reticulocyte cell free system. This
prourokinase appears to be the precursor of both the A and B chains of
human urinary urokinase.
Human tissue type plasminogen activator has been obtained by
expression of its cloned gene in a mammalian cell system. Thus,
plasminogen activator is currently synthesized by recombinant DNA
technology for commercial purposes and an easy purification technique is
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highlY desirable.Highly purified plasminogen activator promises
practical approach for coronary thrombosis in patients with acute
myocardial infarction (Van De Werf

~

.ala., 1984).

Tripeptide substrates for plasminogen activators shows its
specificity for synthetic peptide sequences. Val-Gly-Arg and Glu-Gly-Arg
tripeptides are specific toward both tissue-type plasminogen activator
and urokinase. In addition to these two tripeptides, Gly-Gly-Arg and pGlu-Gly-Arg also show a high specificity towards both types of
plasminogen activators (Cleason and Aurell, 1981). The aldehyde
derivative of these tripeptides should also be highly specific and
potent inhibitors of plasminogen activator. These tripeptide aldehydes
could be used as ligands for preparation of affinity adsorbent for a
single step purification plasminogen activators. Among all the
tripeptide aldehydes,

Gly-Gly-Argal would be the easiest to synthesize.

The urokinase purified using this affinity adsorbent will be expected to
be free from other contaminating proteases and proteins.
~

Thrombin
Thrombin is a proteolytic enzyme homologous to trypsin,

chymotrypsin and elastase with Mw-34,000. The biology and chemistry of
thrombin has been extensively studied over the last fifty years. Major
attention has been paid to the kinetics and the inhibition of the
proteolytic action of thrombin on fibrinogen. Thrombin is the enzyme
involved in the final step of the coagulation of mammalian blood. In
this step four Arg-Gly bonds are cleaved releasing four fibrinopeptides.
While it is a highly specific protease, it has a wide specificity
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towards small synthetic substrates. It is clear that thrombin exists in

multiple covalent forms which have different specific activities towards
fibrinogen and ester substrates. These forms are referred to as
thrombin, ,B-thrombin (fig.11 ). ,B-thrombin is formed from

-~

~thrombin

by

the extensive degradation of the A chain and excision of a small
fragment containing carbohydrate, from B-chain. This results in a threechain structure. 2(-Thrombin arises from further degradation of the B2
chain. Fig 11 shows structures of bovine

oc,p and 'd-thrombin

(Lundbald,

1976). The relative activities of.oC-thrombin and,B-thrombin toward
fibrinogen is 21.6 to 1.0 indicating a major contribution of theO(-form
towards clotting activity. However, their relative activity toward the
small synthetic substrates Bz-ArgNaN is only 5.25 to 1.0 (Workman and
Lundblad, 1977).
Even though there are a number of known protein substrates for
thrombin, the kinetics and chemistry of fibrinogen-fibrin conversion by
thrombin is the most extensively studied. Fig 12 shows a primary
structure model of human fibrinogen. In the Figure, the chains have been
aligned according to homology, the N-termini pointing towards the
middle. The connecting links represent disulfide bridges, the arrows
point to the thrombin cleavage sites and the diamonds point to
carbohydrate side chains. Fibrinopeptides A and B are peptide fragments
released from amino-terminal portions of fibrinogen upon thrombin
catalyzed gelation. The physiological role of these peptides in the
protein is to prevent spontaneous polymerization of the fibrinogens. The
amino acid sequence and length of fibrinopeptides A and B is species
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dependent, indicating they can serve as markers for studying phylogenie
relationships and the evolutionary process of primates on a molecular
level (Nakamura

~ ~

1983).

Fig 13 shows the amino acid sequences of

human and bovine fibrinopeptide-A (FPA) and fibrinopeptide-B (FPB). The
kinetics of the released of the fibrinopeptides show an initial and
rapid released of FPA, followed after a lag phase by the release of FPB.
The A and B chains behave independently in their competition for
thrombin. Phosphorylation of the Ser-3 of the A chain appears to
increase the rate of its release, due to enhanced binding of thrombin
(Hanna and Scheraga, 1984).
Initially thrombin was purified by ion-exchange chromatography.
Baughman and Waugh (1967) used a combination of DEAE-Cellulose
chromatography, phosphocellulose chromatography and gel-filtration to
obtain a preparation with a specific activity of 2100 NIH U/mg for
bovine thrombin. Affinity chromatography for purification of thrombin
using p-aminobenzamidine as a ligand has been reported (Schroer, 1972;
Hixon, 1973). The benzamidine agarose is a potent affinity adsorbent for
thrombin. From crude thrombin, a 16-fold purification was obtained. The
preparation also contained small amounts of plasmin and had to be
further purified on SE-sephadex column to obtained 2000 NIH U/mg
thrombin with an overall yield of 50% to 60%.

-OC-

Electrophoresis showed a

major and a minor band on a SDS-gel. In the elution of thrombin from the
benzarnidine resin, 0.05M p-arnino-benzarnidine in Tris-KCl buffer at pH8.0 was utilized (Hixon and Nishikawa, 1973).
Heparin acts as an anti-coagulant on binding to thrombin at a site

Fibrinopeptide-A (FPA)

Human:-

Ala-Asp-Ser-Gly-Glu-Gly-Asp-Phe-Leu-Ala-Glu-Gly-Gly-GLy-Val-Arg.

Bovine:- Glu-Asp-Gly-Ser-Asp-Pro-Pro-Ser-Gly-Asp-Phe-Leu-Thr-Glu-Gly-Gly-Gly-Val-Arg.

Fibrinopeptide-B (FPB)

Human:-

p-Glu-Gly-Val-Asn-Asp-Asn-Asn-Glu-Glu-Gly-Phe-Phe-Ser-Ala-Arg.

Bovine:- pcA-Phe-Pro-Thr-Asp-Tyr-Asp-Glu-Gly-Gln-Asp-Asp-Arg-Pro-Lys-Val-Gly-Leu-Gly-Ala-Arg.

Figure-13. Amino acid sequence of fibrinopeptides.
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other than the catalytic site.

This property of heparin was exploited

for preparation of an affinity adsorbent for thrombin (Miller-Anderson,
1980; Funahashi, 1982). Three different types of heparin-Sepharoses can
be prepared. First, by the coupling of carboxyl groups of heparin with
amino-Sepharose. Secondly by the coupling amino groups of heparin with
carboxyl-Sepharose, and, thirdly, by the reductive amination of heparin
and amino-Sepharose with sodium cyanoborohydride. Among these three
types of heparin resins, the third type was found

to be the most

efficient affinity adsorbent for thrombin and anti-thrombin III
(Funahashi, 1982).
Miller-Anderson (1980) combined all three techniques, ion-exchange
chromatography, gel-filtration and affinity chromatography to prepare a
human thrombin standard. In the procedure, a prothrombin complex was
activated and purified on a CG-50 ion-exchange column followed by
chromatography on SP-Sephadex and then chromatography on heparinSepharose. The resulting thrombin had a specific activity of 2400 to
2850 IU/mg.
These methods are lengthy and if used alone, are not exclusive for
thrombin. Heparin has affinity not only for thrombin, but also for
antithrombin III, lipoprotein lipase, collagenase, DNA polymerase and
number of other biomolecules. Benzamidine-Sepharoses are specific for
all trypsin-like proteases and bind thrombin, urokinase, plasmin,
trypsin, etc. A single step purification affinity adsorbent could be
prepared using a specific active site inhibitor of thrombin as a ligand.
As discussed previously Phe-Pro-Argal offers the required
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characteristics for this purpose. Accordingly, in this dissertation an
Affi-gel-Phe-Pro-Argal .resin will be prepared and tested for its utility
as an affinity adsorbent for the purification of thrombin.
The amino acids in fibrinopeptides from many species differ in the
p2 and P3 positions. The Phe at position Pg is conserved, suggesting
the importance of Phe in Pg position for thrombin action. Marsh and
Scheraga (1982) synthesized the fibrinopeptide sequences Ac-Phe-Leu-AlaGlu-Gly-Gly-Val-Arg-Gly-Pro-NHCH3 (F-6) and Ac-Leu-Ala-Glu-Gly-Gly-GlyVal-Arg-Gly-Pro-NHCH3(F-7) and the rates of hydrolysis of Arg-Gly bond
in these peptides by thrombin were measured. The rate for the Phe
containing peptide F-6 was found to be significantly larger than that
for F-7. Indeed, F-7 is such a poor substrate that it was not possible
to obtained Michaelis-Menten parameters. This and previous work
demonstrate that Phe-Leu at position Pg-Pa is very important for
thrombin binding to its substrate. The work was extended further to
investigate the importance of Asp at the P10 position, which indicates
that Asp(P 10 ) is also important for thrombin fibrinogen interactions
(Marsh and Scheraga, 1983). On the basis of these observations and high
affinity of Phe-Pro-Arg for thrombin, a hairpin-like structure in the
NH2 terminal of the A chain of fibrinogen is proposed. Additional bends
I

I

,

present at Pro-Arg (P 2-P 3) and poss1bly between P4 and Pa
Phe(Pg) close to Val-Arg-Gly. In other words Phe can occupy

.

br1ng the

s3

position

in thrombin.
This leads to a conclusion that in the design of a small specific
inhibitor of a protease, the selection of amino acid sequence may not
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necessarily have to be based upon substrate sequence. There is one
consolation to this, that is, there are only 20 or so common amino
acids. However, the permutations of these could become very difficult
when dealing with an unknown protease. This problem could be solved by
using the natural substrate of the protease. This plan of attack is
explained in a later section.
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Peptide synthesis
This rather narrow area of bio-organic chemistry has received

considerable attention. It is impossible to review all the methodologies
to synthesize peptides, therefore only cases pertaining to this research
will be discussed. The formation of the peptide bond requires activation
of the carboxyl group of an amino acid. The reactive intermediate of the
amino acid then reacts withoC-NH2 of another amino acid to form the
peptide bond. The reversible protection of the amino group and of the
carboxylic group which were not meant to be part of the amide bond,
remained problematic for a long time. A major break through toward the
solution of this problem was the discovery of the carbobenzoxy group.
This protecting group could be easily removed by catalytic hydrogenation
at room temperature and ordinary pressure, and generates relatively
harmless by products, toluene and carbon dioxide. Since the guanidine
group of arginine is a nucleophile, it should blocked to prevent
undesirable reactions. There are

three amino groups in the guanidine

which is a single, monoacidic cation. The basicity of the guanidine
group in arginine is extreme, and it remains protected under the usual
conditions of peptide synthesis by simple solution protonation. In this
Dissertation, I have N02 protection of the guanidine group to promote
the solubility of Arginine peptides in tetrahydrofuran (THF). This No2
protection can be removed under similar conditions to remove the
carbobenzoxy group, the only difference is the requirement for acid and
a longer reaction time. During deprotection of the N02 , special care
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needs to be taken against the reductive saturation of aromatic nucleui
and other unsaturated bonds (Galpin

~ ~

1984). Other problems with

guanidine protection with N02 are reviewed in detail by Bodanszky
(1984).
The aldehyde function is reactive towards even weak nucleophiles,
and has to be protected from participating in undesirable nucleophilic
reactions. This protection should be easily removable under mild
conditions to regenerate the aldehydic function. There are number of
ways to accomplish this goal. Without going into detail, two distinct
alternatives are either to prepare the acetal or the semicarbazone
derivative. Both methods are easy, but acetals are acid labile and
during removal of the N02 protection of the guanidine group, the acidic
conditions may also remove the acetal aldehyde protection.
Semicarbazones are relatively stable to acids. Also it is advantageous
because of the low solubility of the semicarbazone products, which will
help in crystallization of the aldehyde derivative.
The carbonyl group can be activated in a number of ways. One of the
most popular methods is the conversion of protected amino acids to
reactive esters, Z-NH-CHR-COOR', where R' is an electron-withdrawing
group. From numerous active esters in the literature, N-hydroxy
succinamide esters were selected herein (Anderson, 1963, 1964) because
of the water solubility of the products of the hydrolysis. The N-hydroxy
succinamide esters are crystalline, stable compounds which have
excellent reactivity in aminolysis reactions. The synthesis of N-hydroxy
succinamide esters are not different from the formation of a peptide

7R

bond. The N-protected amino acid is allowed to react with N-hydroxy
succinamide in presence of an acyl transfer reagent, for example a
carbodiimide (Bodanszky, 1957).
In the case of utilization of a carbodiimide catalyst, the
activation of carboxyl group occurs through its addition to N:C double
bond of the carbodiimide. Fig. 14 shows the most commonly used
carbodiimides. Dicyclohexyl carbodiimide (DCC) was introduced by Sheehan
and Hess (1955). The water soluble variant of DCC is N-ethyl-N-(3dimethylaminopropyl) carbodiimide (EDC). There are other water soluble
variants, but EDC seems to give better coupling yields (Bodanszky,
1984). Fig. 15 shows a carbodiimide mediated peptide bond formation. The
by product of the coupling reaction is an isourea. In the case of DCC
the N,N'-dicyclohexyl urea is insoluble in most organic solvents and
removed by filtration. A water soluble carbodiimide is advantageous in
certain cases because of the solubility of the urea by product. This is
particularly useful when the desired product is linked to an insoluble
support.
Proteolytic enzymes also can be used as coupling reagents by
thermodynamically or kinetically controlled enzyme catalyzed aminolysis
of specific acids or esters. In recent years protease catalyzed peptide
synthesis has undergone intensive development. Enzymic synthesis
processes a number of advantages over chemical synthesis. Since it does
not require an activation of a carboxyl group, functional side groups
amino acids do not have to be protected. In addition, these reactions
are stereospecific and undesirable racemization does not occur. Several
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Dicyclohexylcarbodiimdde

HCl

I

CH~C~-N:C:N-C~-C~-N(CH3)2

N-ethyl-N'-(3-dimethylaminopropyl)carbodiimide
(water soluble carbodiimide)

diisopropylcarbodiimide

Figure-14. Structures of carbodiimides.
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carbodiiminde

isourea

Figure-15. Carbodiimide coupling reaction.
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papers devoted to successful synthesis of various peptides using
chymotrypsin, papain, subtilisin, trypsin, carboxypeptidase and other
proteases have been published (Mitin, 1984).
Conditions have to be worked out to shift the equilibrium in such a
manner that the enzyme remains catalytically active and peptide bond
synthesis is favoured rather than peptide bond hydrolysis. Three
different techniques have been applied to achieve this goal, mass action
(Sealock and Laskowski, 1969), change in pH (Mitin

~ ~

1984) and

addition of an organic co-solvent to change the equlibrium in favor of
the peptide synthesis(Homanberg and Laskowski, 1978; 1979).
In the first technique, a des-arg modified protein was reacted with
large quantities of arginine, trypsin and carboxypeptidase-B. This
procedure succeeded in adding the initially removed Arg residue back to
the des-Arg protein. In the second technique, Mitin

~ ~

(1984)

synthesized peptides in the presence of papain at pH 8 to 9 using
acylamino acid alkyl esters as starting substrates and peptide
nucleophiles (amides or tert-butylesters of amino acids as well as
peptides) as amino group donating compounds. In the third technique
(Sealock and Laskowski, 1969), the pH dependence of Ksyn in water and in
60% (v/v) triethylene glycol was varied and conditions found that
thermodynamically

favored peptide bond synthesis in the chymotrypsin

mediated peptide bond formation between Cbz-Try and Glu-NH2• In the
study of the resynthesis of the peptide bond between bovine pancreatic
ribonuclease S and S peptide by subtilisin in water, the maximal amount
of synthesis was only 4.3%. By increasing the glycerol concentration to
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go% (v/v) glycerol, the glycerol perturbed the equlibrium between
synthesis and hydrolysis so that at equlibrium, 50% of the RNAase was in
the natural covalent form.
~

Rational fQr utilization Q[ fibrinogen-thrombin system fQr

~

development Qfa general method !QL protease affinity
chromatography
The example of thrombin was selected to demonstrate a general
method of affinity chromatography herein because the chemistry of
fibrinogen-thrombin system is known.

In addition to this

fibrinopeptides are commercially available and the potential problems of
side chain

coo-

groups modification could be studied. Since the amino

terminal residue of FPB is p-Glu, it is not available to form a linkage
between FPB and the resin matrix. This leaves FPA as the possible choice
for immobilization on the resin. The FPA is immobilized rather than
fibrinogen for two important reasons. First, the activation of
immobilized fibrinogen by thrombin will lead to formation of a large
clot entrapping all the matrix beads. Secondly,

since fibrinogen is a

very large molecule (MW= 340,000), a high ligand concentration can not
be achieved due to molecular weight differences between the by product
fibrin and desired product (FPA). However, a very high concentration
could be achieved on the matrix if FPA is added directly to the resin.
During the coupling of ArgSc to des-ArgFPA, the side chain
groups of glutamate and aspartate have the

coo-

potential to be modified by

the reaction. This problem could be remedied by either the selective
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reversible modification of these acid groups or by the use of an enzyme

reagent to form the peptide bond with a specificity to the C-terminal
carboxylic group. Both approaches are attractive and will be later
discussed.
Fibrinopeptide-A will be covalently joined to an affinity resin by
one of the standard procedures previously discussed. This resin
containing fibrinopeptide-A will be treated with carboxypeptidase-B to
remove the terminal arginine residue. Carboxypeptidase-B is commercially
available in high purity and exhibits preference in the removal of basic
amino acids like arginine and lysine. The release of free arginine from
the peptide can be directly followed by the Sakaguchi test (Messineo,
1966). Following removal of the COOH-terminal arginine, Arg-Sc
(argininal semicarbazone) (Patel and Schultz 1983) will be added to the
desarginine peptide. The simplest way to do this is by a chemical means
utilizing a water soluble carbodiimide to catalyze peptide bond
formation.
An apparent difficulty with this scheme is that the addition of the
Arg-Sc will not only be to the desired COOH-terminal group of the desArg FPA, but also to the Glu and Asp carboxylic acid side chain groups.
Whether the effect of these added Arginals make any difference in the
binding of thrombin to the affinity resin remains to be seen. However,
the nonspecific addition of Arg-Sc could be avoided by revesibly
modifying COOH side chain groups or using proteases as reagent for
peptide bond formation as discussed previously. In the reversible
modification approach, methyl ester protection of these COOH groups is
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very attractive. This protection could be obtained using triethyl
oxonium fluoroborate (Merwein reagent) in aqueous solution (Hamada and
Yonemitsu, 1971; Paterson and Knowles, 1972; Osbahr, 1982). The methyl
esters could be easily hydrolyzed at pH 12 within a short period of time
after the C-terminal arginine is converted to argininal. A number of
different techniques can then be used to substitute the terminal
arginine by Arg-Sc.

Chapter III
MATERIALS AND METHODS

~

General Materials £nd Sources
Unless otherwise stated the chemical reagents utilized in this work

were reagent grade or better. Reagents were generally purchased through
the Eastman Chemical Company, Scientific Products (S/P), J.T. Baker
Chemical Company or from the Malincrodt Chemical Works. Special
instruments utilized in this work are indicated at the appropriate
places.
Specific mixtures of developers (CH 3oH:CHC1 3 :15:90 and others as
indicated) were formulated to develope thin layer chromatography (TLC)
plates were prepared each day and were used only once. Specific spray
reagents were prepared intermitantly as per requirements to maintain
optimum sensitivity. Appropriate buffers were freshly prepared and
stored at 4

°c.

Affinity resins were also stored in CH 3 :H20/50:50 at 20 °C and equilibrited with appropriate buffer overnight before use. The
substrate solutions were prepared according to required concentrations
and stored at -20 °C in 2 ml aliquot. Enzyme solutions also were prepared
according to their desired concentrations and stored at -20 °C in
appropriate aliquots.
Because of its higher sensitivity of silica gel plates Bakerflex
IB2F (fluorescent type) from J.T. Baker Chemicals towards the Sakaguchi
85
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test, IB2F plates were used where the Sakaguchi test was performed. If a
Sakaguchi test was not required, silica gel plates GF from Analtech
(cat# 02521) were used.
Bovine fibrinogen type IV containing approximatly 40% buffer salts
(sodium citrate/sodium chloride::0.02:0.85) was purchased from Sigma
chemicals (cat# F-4753) and was used without further purification.
Human fibrinogen containing approximatly the same buffer salts as
bovine fibrinogen was purchased from Sigma Chemical (cat# F-3254) and
used without further purification. Bovine thrombin was purchased from
Miles Lab. (85 NIH units/mg protein, Lot# 82-03615), bovine trypsin from
Millipore Corp. (LOt# 3703 TRL 39N993P), and human urokinase from Abbott
Laboratories (Abbokinase, Lot# 19-022-AF, 150,000-200,000 I.U/mg
protein).
The following are the spray reagents for identification of
different functional groups in peptide derivatives.
Dinitrophenylhydrazine (DNP) test: To identify aldehydes, aldehyde
hydrates or semicarbazones on TLC, the developed and dried silica gel
plates were initially sprayed with a solution of dinitrophenylhydrazine
(DNP) (Aldrich) in ethanol containing 1% concentrated HCl and dried at
80 °C in an oven for 10 min. To enhance the sensitivity, the plates were
subsequently sprayed with a solution of 0.2% potassium ferricyanide
(Fisher) in 2 N HCl which upon drying destroy the yellow color of
unreacted DNP and the aldehyde or semicarbazone are amplified by their
yellow color.
Sakaguchi test: The chromatogram is sprayed with a mixture of a 16%
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urea solution followed by 0.2% ethanolico<-naphthol solution. The plate
is dried at 80 °C for 10 minutes and subsequently sprayed with a
solution of 3.3 ml bromine in 500 ml 5% NaOH solution.
Ninhydrin test: 100 mg of ninhydrin was dissolved in 100 ml of
acetone. After spraying the chromatogram with the ninhydrin solution, a
pink to purple color appears upon heating at 80 °C for 10 min.
Iodine chamber: A few crystals of iodine are kept in an air tight
wide-mouth glass jar and a dried chromatogram is allowed to react with
the iodine vapor for 10 min.
Schiff's reagent: 1 gm of basic fuchsin (Sigma Chemicals) is added
to 200 ml of distilled water at 90 °C and stirred to disolve. The
solution is cooled to 50 °C, filtered, and 20 ml of 1 N HCl added. The
solution is further cooled to 25 °C, 1 gm of sodium bisulfite added, and
the solution kept for 18-20 hours in the dark. To the straw colored
solution, a few grains of activated charcoal is added to decolorized
the solution. The reagent is stored at 4

°c

in a tightly stoppered brown

bottle. The solution is discarded when a pink color appears.

~

Synthesis

Q[ Cbz-(NO~)-L-Arginine

Semicarbazone

(Cbz-NO~-Arg-SC

I have published the synthesis of this compound (Patel and Schultz,
1982). To a solution of 2.02 gm (5.72 mMoles) of Cbz-N02-Arg in 15 ml of
anhydrous tetrahydrofuran (THF)(Malincrodt) under nitrogen was added 1.0
gm of 1,1'-carbonyl diimidazole (Sigma). The solution was stirred at 10
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oc

untill all the solids dissolved and then cooled to -75 °C (dry-ice

acetone bath). To the solution was added 0.84 gm of LiAlH 4 in 17 ml of
THF over 30 minutes and the mixture stirred for 3 hr at -75 °C under N2.
Unreacted LiAlH 4 was decomposed by the addition of 50 ml cold 2N HCl to
pH-3.0. The reaction was extracted 3 times with CHC1 3, the CHC1 3 extract
washed with H2o, dried over anhydrous Na 2so4 , filtered and evaporated to
dryness under vacuum on a rotary evaporator. The white residue (impured
Cbz-N02-Argal) was dissolved in 80 ml of 70% ethanol to which 1.20 gm of
semicarbazide.HCl and 1.84 gm of sodium acetate were added. The solution
was warmed briefly to 60 °C and the solvent evaporated under vacuum. The
residue was purified on a silica gel column eluted with 10% CH 30H in
CHC1 3, yielding 1.5 gm (66.4% yield) of Cbz-N02-Arg-Sc, crystallized
from absolute ethanol, mp. 105-108 °C (uncorrected) (Lit. 107-109 °C),
TLC over silica gel GF plates gave a single spot of Rf=0.19 in
90:15::CHCl 3 :cH 30H.
~

Removal

Q[

CBz £nd

NO~

protection frQm

CBz-NO~-Arg-Sc.

Cbz-N02-Arg-Sc (50 mg) was dissolved in 20 ml of CH 30H. To the
solution was added 5 mg of palladium black (Aldrich Chemical Co), 5 ml
of H2o and 0.2 ml glacial acetic acid. The mixture was placed in a Parr
hydrogenator, reduced for one hour at room temperature and 5 lb/in2 of
hydrogen gas pressure. The mixture was then subjected to centrifugation
to remove the catalyst. The catalyst was washed twice with 5 ml portions
of CH 30H to recover adsorbed Arg-Sc from the catalyst. The washings and
supernatent were combined and evaporated at 30 °C to drynes under vacuum
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in a rotary evaporator. To the concentrated Arg-Sc was added 10 ml of
H20 and then the solution was evaporated (to dryness to remove traces of
acetic acid). The residual Arg-Sc was used in experiments without any
further purification.
~

Synthesis

Q[ Cbz-NO~-Arginine

diacetal

3

(Cbz-NO~-Arg-OCH ll

A solution of 2.02 gm (5.72 mMoles) of CBz-N02-Arg in 15 ml of
anhydrous THF under nitrogen was stirred at 10 °C until all the solids
dissolved, and then cooled to -75°C (dry-ice acetone bath). To the
solution was added 0.48 gm of LiAlH 4 in 17 ml of THF over 30 minutes and
the mixture stirred for 3 hrs at the same temperature under N2•
Unreacted LiAlH 4 was decomposed by the addition of 50 ml of cold 2 N HCl
to pH 3.0. The reaction was extracted three times with CHC1 3, the CHC1 3
extract washed with H2o, dried over anhydrous Na2so 4, filtered and
evaporated to dryness under vacuum on a rotary evaporator. The white
residue was dissolved in 20 ml CH 30H and to the solution was added 4 gm
of sodium bisufite in 20 ml of water. The solution was stirred at room
temperature for 20 minutes. The pH of the solution was adjusted to 6.8
to 7.0 with sodium carbonate and let it stirred for an additional 20
minutes.

The solution was washed three times with 50 ml CHC1 3. The pH
of the solution was adjusted to 9 to 10 and was evaporated under vacuum
on a rotary evaporator to 20 ml. The solution was extracted three times
with CHC1 3, the CHC1 3 extract washed with H2o, dried over anhydrous
Na 2so 4, filtered, and evaporated to dryness under vacuum on a rotary
evaporator, yielding 1.21 gm Cbz-N02-Argal (70% yield). The aldehyde was
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dissolved in 100 ml of absolute methanol and 200pl of concentrated HCl

added in 50JU1 portions with stirring, and the reaction mixture stirred
ror 10 minutes. The Cbz and N02 protections were removed by catalytic
hydrogenation as described before and was used without any further
purification.
~

Activation Qf Enzacryl AH
Enzacryl AH (100 mg) was placed into a test tube and stirred in 10

ml of 2 N HCl at 0-5°C. To the mixture, 4 ml of 4% ice-cold sodium
nitrite was added with stirring, the mixture stirred for 15 minutes, and
the resulting diazo-enzacryl AH washed four times with 5 ml portions of
borate buffer (pH-9.2). The resin was added to a solution of 28 mg of
Arg-Sc in 5ml borate bufer/10 ml methanol and stirred over night. The
next day the resin was collected on a sintered glass funnel and washed
with 0.01 N borate solution. Excess unreacted active groups were
neutralized by stirring the resin in 1 M ethanol amine (pH 9) for one
hour.

~

Synthesis Q( Affigel-Argal Resin.
Cbz-N02-Arg-Sc (50 mg) was reduced as described above and the

resultant Arg-Sc dissolved in 4:1/ CH 30H:phosphate buffer (0.025 M sodium
phosphate, pH 7.5), and the solution cooled to 4 °C. Affigel-10 (7 ml)
(Bio-Rad Corp.) was collected in the sintered glass funnel and washed
three times with 7 ml portions each of isopropanol. The washed gel was
added to a pre-cooled Arg-Sc solution, shaken over night at 4 °C, the
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resin washed with CH 30H:H2o (4:1) to remove excess Arg-Sc, the resin
added to 10 ml of 1 M ethanol amine at pH 8.0, stirred for two hours, the
resin collected and washed with H2o. To remove the semicarbazone
protection, the resin was added to a solution of CH 30H:CH 3COOH:HCHO
(5:1:1) and stirred overnight at room temperature. The Affi-Argal resin
was collected on a funnel, washed with H2o, and equilibrated in the
protease binding buffer prior to the use.
~

Synthesis Q(

~

Ethanolamine Resin

To 10 ml of Affigel-10 was added 10 ml of 1 M of ethanol amine at
pH-8.0, the mixture mixed for mixed for 3 hrs at room temperature, the
resin collected on a funnel and washed with cold H2o. The resin was
stored as described previously.
~

General Procedure EQr

~

Synthesis Q( R-{X-Y-Arginal) Resins

The affinity resins of general formula R-(X-Y-Arginal) were
prepared by dissolving 50 mg of the respective dipeptide -X-Y- (-X-Y-=
Phe-Ala, Phe-Pro, or Gly-Gly) in a solution of methanol/buffer (0.025M
sodium phosphate at pH-7.5), cooling to 4 °C, adding 5 ml of washed
affigel-10 and the mixture shaken over night in an inverting shaker at
4 °C • The resin was collected on a sintered glass funnel, washed with
methanol/water, the resin added to 10 ml 1 M ethanol amine (pH-8.0) to
block any unreacted N-hydroxy succinimide ester groups, the mixture
shaken for 5 hrs, the resin collected on a funnel and washed with water.
The R-(X-Y) resin was then added to a 4:1 methanol/water solution
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containing 50 mg of Arg-Sc and a 5-10 fold molar excess of water soluble
carbodiimide (EDAC, Pierce Chemical Co), the solution brought to pH 4.5,
and mixed in an inverting shaker over night at room temperature. The
resin was collected on a sintered glass funnel and washed with 4:1
methanol/water, the washed resin added to a solution of 3:1:1 methanol/
acetic acid/ formaldehyde (37%), and mixed overnight in an inverting
shaker to remove the semicarbazone protection and generate the free
argininal. The resin was collected on a sintered glass funnel, washed
with water and equilibrated with buffer prior to use.
~

Chemical Analysis

Q(

Resins

1. Chemical analysis for guanidine function
Chemical analysis for guanidine function in resins and solutions
was carried out similar to a method described by Messineo (1966) with
modifications described: The reagents were prepared in the following
manner:
Reagent A:- Four hundred mg of KI was dissolved in 100 ml of deionized
water.
Reagent B:- To 100 ml of 2 M KOH was added 2 g of potassium sodium
tartarate, followed by 100 mg of 2,4-dichloro-1-naphthol (Eastman Chern.
Co.). To the solution, 180 ml of 95% ethanol was added. The solution was
allowed to stand overnight before use.
Reagent C:- Twenty ml of commercial NaOCl (approximate concentration 46%) was diluted with 80 ml of deionized water.
For qualitative and quantitative analysis of guanidine function,
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the reagents were used in the following manner: To the resin or the
sample solution in acidic medium (pH 1 to 2) containing 1 to 5 ug of
arginine, 0.3 ml of reagent A and 1.0 ml of reagent B were added in this
order. After standing for few minutes at room temperature, 0.2 ml of
reagent of reagent C was added. After 10 minutes the absorbance was
measured against a blank at 520 nm. One or two standards were used each
time to assure accuracy for variations in different batches of reagents.

2. Aldehyde concentration in the resin.
Quantitative analysis for the aldehyde concentration in the resin
was based on an analytical procedure previously described by Ulbrich and
Schellenberger (1979) (Patel and Schultz (1982)) as follows. To 0.1 ml
of Argal-resin was added a saturated solution of p-phenyl-azoaniline in
ethanol and acetic acid (10:1), the mixture incubated for 1 hr, and the
resin washed with ethanol until the eluent is colorless. The resin is
added to 1 ml of 8:1:1 methanol:acetic acid:salicyl aldehyde and shaken
for 30 min, the supernatent collected, and the procedure repeated 2 more
times with the same solvent. The supernatents are combined, made up to
5.0 ml, and the absorbance read at 405 nm with respect to a solution
obtained by treatment of model ethanol amine-resin in the same way. The
excitation coefficent for the Schiff adduct of p-phenyl-azoaniline and
salicyl-aldehyde was determined on a sample of this product
independently synthesized by procedure previously described (Patel and
Schultz, 1982).
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General procedure

1. Preparation of fibrinopeptides:
To the solution of 0.9% NaCl was added 1 g of either human or
bovine fibrinogen and was stirred to dissolve at pH 8.5. To the
solution, 20 units of purified thrombin and 0.5 ml of 2.5 M CaC1 2 was
added, the fibrin clott removed as it is formed by a glass rod, and the
stirring continue for six hours. The solution was filtered through
Whatman #1 filter paper followed by filtration through a PM-10 membrane
filter (Millipore Corp.) under 20 atm. N2 pressure. The filtrate was
evaporated at 30 °C under reduced pressure to dryness in a rotary
evaporator. The residue was extracted with 20 ml mixture of
methanol/water (50:50) and the supernatant evaporated to dryness. The
residue was now extracted in to 10 ml CH 30H/H2o (75:25) and the
supernatent evaporated to dryness. The residue was reconstituted in 2.5
ml 0.9% NaCl and loaded on a G-25 superfine Sephadex column (2.5x10 em).
The column was eluted with the same NaCl solution at flow rate of 1
ml/min. The peaks determined at 280 om were collected
2. Synthesis of Affigel-fibrinopeptide-A resin (Affi-FPA)
Fibrinopeptide-A was dissolved in 4 ml of CH 30H/0.05 M imidazole
(75:25), adjusted to pH 7.4, and cooled to 4 °C. Affigel-15 (7 ml) (BioRad Corp.) was collected in sintered glass funnel and washed three times
with 7 ml portions of isopropanol followed by a 10 ml wash of CH 30H/H2o
(75:25). Washed gel was added to pre-cooled FPA solution, shaken for two
hours at 4 °C, to the slury was added 5 ml of 1 M ethanolamine (pH 8.0),
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shaken for 4 hrs at room temperature, the resin collected, and washed
with H20.

3. Synthesis of Affigel-Fibrinopeptide-A-Argal resin (Affi-FPA-Argal)
Direct substitution: Affi-FPA and Arg-Sc were prepared as described
previously. To the solution of Arg-Sc in 10 ml CH 30H/0.1 N NaHco 3 (5/5),
in a screw cap test tube Affigel-FPA was added. To the mixture, 0.2 ml
of carboxypeptidase-B (Type I -DFP, Sigma Chemicals, cat# C 7261, 2
units/ml in saline) was added and the solution shaken overnight at 37
°C. Similar reactions were carried out in variable relative amounts of
methanol and buffer, or with ethylene glycol or other organic solvents
in place of methanol.
Chemical method: Affi-FPA and Arg-Sc were prepared as described
previously Affi-FPA was suspended in 4 ml of 1 M ethanol amine at pH 8.0
and 200 mg of water soluble carbodiimide (EDAC) was added, reacted
overnight at room temperature, the resin collected on sintered glass
funnel and washed three times with water. The resin then was suspended
in 4 ml of 0.05 M Tris buffer pH 8.1 and reacted with 0.05 mg trypsin
(Sigma Chemicals, 2X crystallized), or with 100 units of bovine thrombin
(Miles Laboratories, cat# 82-036-1, Lot# 45) for one hour at room
temperature. To remove the terminal arginine, Affi-FPA was suspended in
0.1 M NaHco 3 and 0.2 ml of carboxypeptidase-B (2 U/ml in saline) was
added and reacted for variable lengths of time (30 min to overnight) at
room temperature or 37 °C. Affi-desarginine FPA was collected in a
sintered glass funnel and washed three times with normal saline. The
resin was then added to a 4:1 methanol/water solution containing
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arginine semicarbazone and 200 mg EDAC, the solution brought to pH 4.5,

and mixed in an inverting shaker overnight at room temperature. The
resin was collected on a sintered glass funnel and washed with 4:1
methanol/water, the washed resin added to a solution of 3:1:1
methanol/acetic acid/formaldehyde (37%), and mixed overnight in an
inverting shaker to remove the semicarbazone group and generate the free
argininal. The resin was collected on a sintered glass funnel, washed
with water and eqilibrated with buffer prior to use.
In addition to the ethanol amine protection for side chain

coo-

groups, -OCH 3 protection was also attempted. To 1 mg of human
fibrinopeptide-A in 2 ml of methanol/water (3:1) was added 120 ul of
trimethyloxyfluoroborate (TMOFB) (CH 3)30(BF4) in CH 3CN (100 mg/ml) in
10 ul fractions during 30 minutes. During addition of the reagent, the
pH was kept between 4.5 to 5.5 with the addition of 0.5 M NaOH. The pH
was adjusted to 7.0, stirred for 30 minutes at room temperature, and
cooled down to 4 °C. Affigel-15 (7 ml) was washed with isopropanol as
described before, and reacted with above solution for 60 minutes at 4
°C, 3 ml of 1 M ethanolamine added, and mixing was continued for an
additional one hour at room temperature. The resin was collected on a
sintered glass funnel and washed with water. The gel was added to 4 ml
of 0.025 M imidazole containing 0.2M NaCl, 0.025M CaC1 2 , and 0.01%
carbowax-20M at pH-7.4. To the mixture 10 units of thrombin were added
and reacted for one hour at room temperature. The gel was collected on a
sintered glass funnel and washed with saline. The terminal arginine was
removed with carboxypeptidase-B as described previously Arg-Sc was added
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back to the Affi-desarginine-FPA using water soluble carbodiimide as
described previously. Semicarbazone proction was removed and the resin
equilibrated with buffer prior to use.

Enzymatic synthesis: In this approach papain was used as the reagent to
form the argininal resin peptide bond at pH 9.2. Affi-desArg-FPA was
prepared as described previously. The resin was suspended in 3.5 ml
potassium phosphate buffer containing 0.2 M dithiothreitol, 60 mg of
Arg-Sc, and 0.2M EDTA at pH-9.2 and 0.5 ml CH 30H was added to it. To the
mixture, 200 ul of papain (Sigma Chemical, CatD P-3125, 2X crystallized,
22 mg protein/ml, 22 U/mg protein) was added, the pH adjusted to 9.0,
and the reaction stirred at room temperature. for 15 minutes. The resin
was colected on a sintered glass funnel and washed with water.
Semicarbazone protection was removed, and the resin equlibrated with
water prior to use.
3K

General procedure fQr

1. Column chromatography:

~

binding anQ elution Qf proteinases

The equilibrated 3 ml of resin in an

appropriate buffer was placed in a small polypropylene column attached
to an ultraviolate detector (280 nm) with fraction collector. The
protease solution (1 ml) was diluted with 1.5 ml of the appropriate
buffer and placed onto the resin. The resin was washed with 7.5 ml of
initial buffer. The resin was washed with 10 ml aliquots of the same
buffer, but with a higher ionic strength due to the presence of an
increasing concentration of NaCl in the buffer. Each of the 10 ml
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aliquots were analyzed for absorption at 280 nm, for protein
concentration, and enzymatic activity with an appropriate substrate. In
some cases smaller fractions were obtained in order to better analyze
the pattern of proteases.
2. Enzyme assays:

Chymotrypsin and trypsin were assayed with BzTyrEE

and TosylArgEE respectively, according to the methods described in
Worthington enzyme catalog (Worthington enzymes, 1977).
Bovine thrombin and human urokinase were routinely assayed with
peptide p-nitroanilide substrates in which the rate of appearance of pnitroaniline product was determined at 405 nm with a Perkin Elmer
spectrophotometer (Model# 320). The composition of the reaction
solutions were as follows.
Urokinase: at 37 °C
0.100 ml 1x1o-3 M p-Glu-Gly-Arg-pNA (Kabi Group Inc, S-2444)
0.8 ml 0.05 M Tris buffer pH 8.4
0.2 ml protease test solution
Thrombin:

at 25 °C

0.05 ml 1x1o-3 M D-Phe-Pip-Arg-pNA (Kabi Group Inc. S-2238)
0.95 ml 0.05 M Tris buffer pH 8.4
0.020 ml protease test solution
In some experiments thrombin activity was also measured with the
substrate fibrinogen which measures mainly the activity of the

~

form of the thrombin (Fenton, 1981). In this assay, a stock fibrinogen
solution (50 mg fibrinogen in 25 ml 0.05 Tris containing 3 mM EDTA, pH
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7.4) was filtered and adjusted to 1.0 absorption units at 280 nm. This
solution (200 )Jl) was placed into a Fibrometer (B.B.L., Bectin Dickinson
and Co), 50 ul of Tris buffer pH 8.1 added, followed by 50 ul of the
test thrombin solution in the eluting buffer from the affinity resin,
which always contained 25 mM CaC1 2• The time interval for formation of
fibrin clot was correlated with a standard curve of thrombin units ~
cloting time, prepared previously under identical conditions.

Chapter IV
RESULTS

4A

Synthesis

Q(

Cbz-N02-Arg-Sc

Because of the difficulty of direct reduction of carboxylic acids
to aldehydes, a number of activated carboxylic acid derivatives such as
acid halides, t-amides esters and lactones have been utilized as
substrates for reduction. The problem is to stop the reduction at the
aldehydic stage because the aldehyde once formed is easily further
reduced to the alcohol derivative. Alternatively, alcohols can be
oxidized to aldehydes by number of oxidative procedures. Thompson (1973)
carried out

the oxidation of the alcohols by the dicyclohexyl

carbodiimide-dimethyl sulfoxide reagent, first introduced by Pfiztner
and Moffatt. Oxidation with pyridinium dichromate seems to cause
considerable racemization, but Hamada and Shiori (1982) reported
oxidation of N-protectedf3-amino alcohols by the use of a combination
sulfur dioxide-pyridine complex and dimethyl sulfoxide in the presence
of triethyl amine to give highly optically activeo(-amino aldehydes.
Anderson and Wolfenden (1982) reported the use of horse liver alcohol
dehydrogenase which shows a broad specificity for its alcohol substrates
in oxidation

of~-amino

alcohols tooC-amino aldehydes.

Despite of difficulty in the direct reduction of carboxylic acids
to aldehydes, a few methods have been reported that utilized strong
reducing agents like lithium methyl amine, bis(N-methyl-piperidynyl)
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aluminum hydride, thexylborane or grignard reagents catalyzed by
dichloro-bis(cyclopentadienyl) titanium. These methods lack general
applicability and chemoselectivity because of severe reaction
conditions. Fujisawa

~ ~

(1983) introduced a simple and

chemoselective procedure using N,N-dimethyl chloromethylenimium chloride
and LiAlH(OBut) 3 in a one pot operation. When strong reducing agents
like LiAlH4 or LiA1(0But) 3 are used, the reduction could be limited to
the aldehydic stage by decreasing temperature below -50 °C.
Arg-Sc was synthesized by reducing the carbonyl diimidazole ester
of Cbz-(N02 )-Arg with LiAlH4 at -70 °C. Because of unfavourable
solubility of Cbz-Arg at -70 °C in THF, the guanidine group was
protected with the N02 group solely for its the favourable solubility.
The aldehyde function could be protected either by a forming bisulfite
adduct or by Schiff's base formation. Since strong amine nucleophile
forms a stable Schiff's base, semicarbazide, a strong nucleophile, was
selected as a derivatizing agent. Use of a stronger nucleophile than
semicarbazide could present a problem for the regeneration of the
aldehydic function. The optimum conditions for acid catalyzed
semicarbazone formation is around pH 4.0, where the carbonyl oxygen is
partially protonated and the concentration of unprotonated primary amine
' is present in low but appreciable amount. Sodium acetate provides a
conjugate weak acid to provide desirable conditions for the optimum
acid-catalyzed formation of semicarbazone.
The degree of racemization during silica gel chromatography varies
with the structure of the

Cbz~-aminoaldehyde.

Longer retention times
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appear to cause more racemization. The semicarbazone derivatives, in
which keto-enol tautomerism is suppressed, showed little racemization
during chromatography (Ito

~ ~

1975). In the case of Cbz-Argal,

racemization is limited because of the contribution of its non-carbonyl
carbinolamine structure. From the above two arguments, it is safe to
assume that purification of Cbz-N02-Arg-Sc during silicagel
chromatography will lead to little, if any racemization.
4B.

Removal Qf

~ ~

NQZ group protection

The Cbz and N02 protecting groups of Cbz-N02-Arg-Sc are removed by
catalytic hydrogenation over palladium black (Aldrich Chemical Co Cat#
20583-4). The hydrogenolysis was carefully monitored from 2 hrs to
overnight for complete removal of Cbz and N02 groups (time utilized
depended upon the activity of the palladium catalyst). Prolonged
hydrogenolysis produced a side product which was Sakaguchi positive and
DNP negative. Galpin

~ ~

(1984) showed by NMR that some reduction of

the carbon-nitrogen double bond in the semicarbazone derivatives may
occur during hydrogenolysis. To minimize this reduction of the
semicarbazone double bond, the hydrogen pressure was reduced from 25
lb/in2 to 5 lb/in2 when highly active catalyst was used. The reaction
was monitored by the Sakaguchi test and the reaction was stopped at
after a plateau at A520 was achieved in the Sakaguchi test.
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Enzacryl

AH

Enzacryl AH (Koch-light Laboratories Ltd.) is a hydrophilic
copolymer containing acyl hydrazide groups as potentially active side
chains for ligand binding. Fig.16 shows the structural features and
outlin the coupling procedure used with the Enzacryl AH resin. In the
procedure, the polymer is activated by the action of dilute nitrous acid
which converts the acid hydrazides

to reactive acid azide groups.

Primary amino groups will react with the azides at mild conditions (pH
8.0 to 9.5 and 0-5 °C) to form an amide bond. Accordingly, Arg-Sc in
borate buffer was reacted with the azide resin to obtain Enzacryl AHArg-Sc. Since this resin is stable to acids and organic solvents,
regeneration of aldehydic function on argininal was achieved by
treatment of resin with CH 30H/ HCl (2 N)/HCHO (10:2:2).
The association of trypsin and chymotrypsin was studied by loading
a mixture of trypsin and chymotrypsin onto a small column (0.9 em x 5
em) in 0.05 M phosphate buffer. The resin was then washed with 2 ml
portions of same buffer. Table 8 shows enzyme activities in each
fraction. It is evident from the results that the resin failed to bind
either trypsin or chymotrypsin. It was expected that trypsin would bind
to the column, while chymotrypsin would not show any affinity towards
the resin. The retention of some enzyme activity on the column was
nonspecific, and most of the enzyme activity could be easily washed out
with the initial buffer. Failure to show any specificity towards trypsin
by the resin led to the search for a different type of resin.
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Figure-16. Coupling procedure with Enzacryl AH.
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Table 8
Relative enzyme activities in 10 ml fractions of column effluents.
Resin: Enzacryl AH-Argal
Enzyme: Mixture of 0.5 mg Trypsin and 0.5 mg Chyrootrypsin.
Buffer: 0.05 M Phosphate buffer containing 0.1 M NaCl.
~

Eluting buffer

Enzyme activity

Trypsin

Chyrootrypsin

72

65

Second wash

5

9.5

, M NaCl in buffer wash

9

Unbound fraction (Initial)
First wash

1.8
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Affigel-Argal

~

The procedure utilized for the synthesis of Affigel-Argal resin is
outline in Fig.17. The coupling reaction was monitored by the Sakaguchi
test before and after reaction of Arg-Sc with the Affigel. Affigel (2.5
ml) is capable of coupling 30pmoles of Arg-Sc. The resin was also
qualitatively tested for presence of guanidine group in the same fashion
as for the Argal in solution. In a positive guanidine test, the resin
turns a pink color.
The semicarbazone protection group of the Arg-Sc ligand was removed
by treating the resin with CH 30H:acetic acid:formaldehyde (7:1:2)
overnight. In this reaction the semicarbazide is transfered from Arg-Sc
to formaldehyde in a reaction catalyzed by acetic acid. The formation of
aldehyde in this reaction is qualitatively followed by reaction with
2,4-dinitrophenyl hydrazine, which gives a yellow color on the resin.
Alternatively, quantitative analysis of the aldehyde concentration is
carried out by reaction of the Argal-resin with excess p-phenylazoaniline, which forms a Schiff base with the aldehyde groups (Fig.18).
After washing the excess p-phenyl azoaniline from the resin, the
modified resin is treated with salicyl aldehyde, resulting in the
transfer of p-phenyl-azoaniline from Argal-resin to salicyl aldehyde.
This adduct is eluted from the resin and quantitated by its absorbance
at 405 nm. A comparison of the absorption obtained from the p-phenyl
azoaniline salicyl aldehyde adduct from the Argal resin compared to that
obtained with an ethanol amine resin blank showed a minimum of 0.1
pmoles/ml of aldehyde in the Argal-resin.
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dllmldazole

Cbz-~-N02 )-Arg -----~
LIAIH~

aemlcarbazlde•HCI

dlacetate•H-Argai-SC

Affl Gel

Afflgei-Argai-SC

formaldehyde
HOAc

Afflgei-Argal

MeOH

Figure-17. Synthetic scheme utilized in the synthesis
of Argininal liganded affinity resin.
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RESIN-,hg-CHO

+

H2N O N = N - o

p-phenylazoani lin •

salicylaldehyde

Figure-18. Scheme utilized to analyze Argininal-Resin
for aldehyde concentration.
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Association Q( trypsin 2nd chymotrypsin tQ Affi-Argal resin
In a typical experiment, to 3 ml of Affi-Argal resin in 0.025 M

sodium phosphate (pH 6.0) in a small column (0.9 x 5 em) was added a
mixture of 0.5 mg chymotrypsin and 0.5 mg of trypsin. When the resin was
washed with pH 6.0 buffer, in the first 10 ml eluted 100% of the
chymotrypsin activity placed on the column. The trypsin activity
remained bound to the resin even after exhaustive washing. The elution
of trypsin activity was not possible even with 2 N NaCl or at pH values
between 2.0 and 6.0 (Table 9). However, essentially all the trypsin
activity was eluted from Affi-Argal resin after incubation of the resin
with 0.1 N semicarbazide and 0.1 N sodium acetate (pH 3.8) for 15 to 30
min, and then eluting the trypsin in 10 ml of same reagent.
Control experiments were carried out utilizing Affi-Arg-Sc and
Affi-ethanol amine resins. To the Affi-ethanol amine resin no affinity
of either chymotrypsin or trypsin was observed in pH-6.0 (0.025M sodium
phosphate) buffer. The trypsin associated with the Affi-Arg-Sc resin at
pH 6.0 (0.025M sodium phosphate) buffer, but was elute in 1N NaCl
phosphate buffer at pH-6.0.
~

Affigel-X-Y-Argal

~

1. Synthesis: The procedure utilized for the synthesis of dipeptidyl
Argal-liganded resin is outlined in Fig.19. The resin matrix containing
a ten atom diaminoethyl spacer arms activated as N-hydroxy-succinimide
esters was first covalently linked to dipeptides -X-Y- (where -X-Y-=Phe-
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Table 9
Relative enzyme activities in 10 ml fractions of column effluents.
Resin: Affi-Gel-Argal
Enzyme: Mixture of 0. 5 mg Trypsin and 0. 5 mg Chymotrypsin
Buffer: 0.025 H sodium phosphate pH 6.0
~

Enzyme activity

Eluting buffer
Trypsin

Chymotrypsin

Initial buffer (unbound)

0

90

0.2 M NaCl in buffer wash

0

5

2 H NaCl in buffer wash

0

0

10 ml Saline
(between pH-2.0 and 6.0)

0

0

0.1 N Semicarbazide in
0.1 N NaOAc pH-3.8

100

0
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NaOAc

H,IPd

Argai-SC dlacetate t - - - - - Cbz-(w-N0 2)-Argai-SC

l

dipeptide
Afflgel-dlpeptlde ~-----

Afflgel

pH 7.5

EDAC

Afflgel-dlpeptldyi-Argai-SC

-----~

Afflgel-dlpeptldyi-Argal

HOAc

Figure-19. Synthetic scheme utilized in the synthesis
of dipeptidyl-Argininal liganded affinity resin.
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Pro, Phe-Ala or Gly-Gly), and then the carboxy terminal of -X-Y- joined
to Arg-Sc in the presence of a water soluble carbodiimide. It was found
easier to synthesize the tripeptide aldehyde ligand on the resin in a
two-step, solid phase procedure than to synthesize in solution the
complete tripeptide aldehyde and then attach it to the resin. The
tripeptide synthesis on the resin is N-terminal to C-terminal, which is
opposite from the commonly utilized Merrifield solid phase peptide
synthesis. A disadvantage of our N-terminal to C-terminal synthetic
procedure is that the amino acid Y in the Affi-X-Y resin may be expected
to racemize during its joining to Arg-Sc. However, the affinity of the
liganded resins to their selective proteinase was observed to be
sufficient, and the racemization of the amino acid residue in Y, may
therefore, not be a serious disadvantage. Furthermore, in the examples
studied in this work, the Y residue was frequently Gly or Pro, which
either does not racemize or racemizes with difficulty.
The semicarbazone protecting groups in the Affi-X-Y-Arg-Sc resins
were removed by incubating the semicarbazone derivatized resins in 3:1:1
methanol/acetic acid/formaldehyde (37%) overnight. Our procedure
successfully substitutes a weak acid for the commonly utilized 0.5-2.0 M
HCl as the acid catalyst in previous reported procedures (Nishikata et
al, 1981; Ishii and Kasai, 1981). All resins gave a positive test when
tested by the Sakaguchi test, as described previously, and gave a
minimal aldehyde content of between 0.07 and 0.1 umole/ml of resin. This
analytical procedure for quantitation of aldehyde function. may
significantly under-estimate the aldehyde content as the yield of the
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aldehyde chromophore adduct in the analysis is probably less than 100%
(Patel and Schultz, 1982).
2. General procedure for the binding and elution of proteases:

The

conditions for binding and elution from Affi-X-Y-Argal resins (-X-Y-=
Phe-Ala, Phe-Pro, Gly-Gly) of the serine proteinases trypsin, thrombin
and urokinase was shown in this work. These enzymes have an identical
primary site specificity toward arginine, but differing secondary site
specificities towards residues in substrates N-terminal to the amino
acid containing the scissile peptide bond in their substrates.
The higher ionic strength buffers decreases the the strength of
non-covalent ionic interaction and may be expected to elute proteinases
only bound electrostatically to the resin. For example, proteinases can
often be remove from affinity resins containing lysine, benzamidine or
protease inhibitor ligands in buffers of high ionic strength. However,
in all cases in which the peptidyl argininal showed a high specificity
to a particular protease (i.e., Gly-Gly-Argal for urokinase and Phe-ProArgal for thrombin), the protease could not be removed with high ionic
strength buffers. Tables 10, 11 and 12 shows protease activities in
eluted fraction for the resins Affi-Phe-Ala-Argal, Affi-Phe-Pro-Argal
and Affi-Gly-Gly-Argal, respectively.
In the case where concentration of salt failed to elute the
protease (urokinase from Affi-Gly-Gly-Argal and thrombin from Affi-PhePro-Argal), the tightly bound protease could be removed in 0.1 M
semicarbazide containing 0.1 M NaOAc, 0.025 M CaC1 2 and 0.01 % Carbowax

114
20M. Carbowax 20M was included in the buffer to minimize non-specific
adsorption of protease molecules to glass and other surfaces.
Semicarbazide reacts with the argininal aldehyde ligands, forming
semicarbazone derivatives of the aldehyde groups, and thus acts to
decrease the affinity of the protease to the resin by decreasing the
concentration of free aldehyde in the resin.

3. The example of thrombin: The thrombin utilized in this study is a
crude commercial preparation from fresh bovine plasma, in which the
proenzyme has been partially purified by ion-exchange precipitated with
other contaminants, and then activated by bovine brain thromboplastin
and calcium. As such it represents a crude preparation of 85 NIH
units/mg protein specific activity, that serves as a starting
preparation for further purification. Purified bovine thrombin has a
reported specific activity of about 2100 NIH units/mg protein (Lundblad
~ ~,

1976).

The sequence Phe-Ala-Argal may be expected to have a selective
affinity to thrombin, based on the observed selective reactivity of the
chloromethyl ketone derivatives of this sequence towards thrombin
(Kettner and Shaw, 1979). Therefore, Affi-Gel-Phe-Ala-Argal resin was
prepared for the study of thrombin binding. Following the application of
between 20 to 200 units of impure thrombin in sodium phosphate buffer
(pH 6.0) onto a 3 ml of Affi-Phe-Ala-Argal resin, approximately 72% of
the enzyme activity bound to the resin. The bound thrombin activity was
eluted in succeeding 10 ml washes of 0.2 and 1.0M NaCl in phosphate
buffer (pH 6.0) and in a 10 ml semicarbazide containing buffer (Table
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Table 10
Relative enzyme activities in 10 m1 fractions of column effluents.
Resin: Affi-Gel-Phe-Ala-Argal
Enzyme: Trypsin and Thrombin (separate experiments)
Buffer: 0.025 M sodium phosphate pH 6.0

J Enzyme activity
Eluting buffer
Trypsin
Initial buffer (unbound)

Thrombin

0

0.2 M NaCl in buffer wash
1 M NaCI in buffer wash

87

37+13

0.1 M Semicarbazide in
0.1 M NaOAc pH 5.0

0

21+6
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10). However, almost all the 280 nm absorbing protein (over 99%) was
eluted in the initial 10 ml buffer, thus giving a dramatic purification
of the thrombin in these later fractions. The thrombin eluted in the
later fractions had a specific activity of equal to was at least 2100
NIH units/mg protein, which is the specific activity reported for
purified bovine thrombin.
While thrombin was purified to a high specific activity on the
Affi-Phe-Ala-Argal resin, the ability to elute a significant amount of
thrombin activity in the 0.2 M and 1.0 M NaCl buffers indicates that
thrombin binding is, to a large extent, electrostatic. However, when the
ligand sequence was changed to Phe-Pro-Argal only 9+2 %of the thrombin
could be eluted with 0.2 M NaCl. The remaining activity apparently bound
strongly, and was only eluted in a semicarbazide containing buffer after
incubation of the resin with semicarbazide for 30-60 minutes to
dissociate the tightly bound thrombin (Table 11). The higher affinity of
thrombin towards Affi-Phe-Pro-Argal is in agreement with the observed
better affinity of thrombin for this sequence in substrate specificity
and peptide inhibitor studies (Cleason and Aurell, 1981). In contrast to
the high affinity shown by the thrombin to the Phe-Pro-Argal resin,
thrombin had no affinity towards the Affi-Gly-Gly-Argal resin (Table 12).
4. The example of urokinase: The sequence Gly-Gly-ArgOH has a selective
affinity towards urokinase and plasminogen activators, as this sequence
has been utilized for the selective assay of these enzymes (Bigbee

~

.al..., 1978). On the application of 500-1000 (I.U.) of urokinase through 3

ml of a Affi-Gly-Gly-Argal resin, the urokinase activity bound tightly
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Table 11
Relative enzyme activities in 10 m1 fractions of column effluents.
Resin:

Affi-Gel-Phe-Pr~Argal

Enzyme: Trypsin, Urokinase and Thrombin (separate experiments}
Buffer: 0.025 M Imidazole containing 0.025 M CaC12 ,
0.01% Carbowax 20M pH 7.0

J Enzyme activities
Eluting buffer
Trypsin Urokinase Thrombin
Initial buffer (unbound)

0

100

0

0.2 M NaCl in buffer wash

3

0

9+2

1.0 M NaCl in buffer wash

0

0

0

10

0

86+3

0.1 M Semicarbazide containing
0.1 M NaOAc, 0.025 M CaC1
.0.01 J Carbowax 20M pH 5.

,
6
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Table 12
Relative enzyme activities in 10 ml fractions of column effluents.
Resin: Affi-Gel--Gly-Gly-Argal.
Enzyme: Trypsin, Urokinase and Thrombin (separate experiments)
Buffer: 0.025 M Imidazole containing 0.025 M CaC12 ,
0.01 J Carbowax 20M pH 7.0

J Enzyme activity

Eluting buffer

Trypsin Urokinase Thrombin
Initial buffer (unbound)

0

0.2 M NaCl in buffer wash

3

1.0 M NaCl in buffer wash

10

0.1 M Semicarbazide containing
0.1 M NaOAc, 0.025 M CaC1
0.01 J Carbowax 20M pH 5.

102

6,

0

88+6
22+6

13

71-82

3

0

119
in the presence of 1.0 M NaCl, and less than 10% of applied activity was
eluted in semicarbazide buffer under standard conditions. Even washing
with 0.1 N HCl and 1.0 M NaCl removed only 30-35% of the bound activity.
However, the addition of both calcium and carbowax 20M (0.01%) to the
eluting semicarbazide and preincubating the resin with the buffer for
30-60 min prior to elution increased the yield of eluted urokinase. In
this way 86+3% of urokinase was eluted with sodium acetate buffer in
0.025 M CaC12 , 0.1 M semicarbazide and 0.01 % carbowax at pH 6.0
(Table 12).
5. Separation of urokinase from thrombin on Affi-X-Y-Argal resins.
Where as urokinase bound strongly to Affi-Gly-Gly-Argal resins, it
was not retarded by the Affi-Phe-Pro-Argal resins, which bound thrombin
strongly. In turn, thrombin had a poor affinity to Affi-Gly-Gly-Argal,
which bound tightly to Affi-Phe-Pro-Argal. Accordingly, the proteinases
could be separated from one another on either of these resins, as shown
in Figures 20 and 21. In Fig.20, the elution of a mixture of 83 units of
thrombin and 500 units of urokinase over Affi-Phe-Pro-Argal is shown.
The two proteases were dissolved in 4 ml of the imidazole buffer (pH
7.0), as described previously, and incubated with the resin with gentle
stirring for 15 minutes. The resin was washed with the original buffer
followed by 10 ml same buffer containing 1.0 M NaCl. All the urokinase
activity and a small amount of the thrombin activity was eluted in these
initial fractions. The buffer was then changed to a semicarbazide buffer
(0.1 M semicarbazide, 0.1 M NaOAc, 0.025 M CaC1 2 and 0.01 % carbowax
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122
20M, pH 6.0), which eluted the tightly bound thrombin activity separated
from the urokinase activity. In Fig.21 is shown the same experiment, but
over the Affi-Gly-Gly-Argal resin. On this later resin, the thrombin
activity is eluted initially, followed by the elution of the purified
urokinase activity in the semicarbazide buffer.
~

Reproducibility
Qf

~

Q(

affinity chromatography results and regeneration

resins

The results reported in Tables 9,10,11 and 12 are for multiple runs
on a single resin preparation of any one kind of resin, that was
continually regenerated after treatment with semicarbazide eluting
buffers by overnight incubation in methanol/acetic acid I formaldehyde
at room temperature. Some of the resins have been regenerated in this
way for more than 40 experiments, without any apparent loss of their
protease binding ability. In fact, over time the binding to a particular
resin by a protease appears to get better, rather than poorer, perhaps
due to a close packing of the resin with use.
Results between different resins preparations of the same sequence
showed a greater variability (10-15%) in each of the initially eluted
percentages over the standard deviation for repeated experiments over a
single preparation of a resin. Accordingly, the procedure for
derivatization is not systemized to yield a consistent titer of ligand
between different preparation of the same sequence. This is perhaps due
to variation of potency of the catalyst used in hydrogenolysis. In later
stages of this work, this factor was minimized by the careful monitoring
of the hydrogenolysis reaction with the Sakaguchi test, as described
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previously. However, whereas differences exist between different
preparations of the same Affi-X-Y-Argal sequence resin, they all show
analogous behavior. Thus, all preparations of Affi-Gly-Gly-Argal showed
a high affinity toward urokinase; and all Affi-Phe-Pro-Argal resins
showed a relatively high affinity toward thrombin and no affinity toward
urokinase.
~

Example
Qll

Q(

a General Procedure !QL Purification

Q(

Proteases

~

Modification Qf Their Natural Hydrolysis Product

1. Preparation of fibrinopeptides: Since fibrinopeptides-A constitutes
less than 1% of the fibrinogen molecule, large amount of fibrinogen was
utilized to get appreciable amount of fibrinopeptide-A. Fibrinogen (1
gm) (Sigma Chemical Co.) was used without further purification. Protein
impurities in commercial preparation with larger than 5000 MW would be
removed during membrane filtration and smaller contaminants will be
removed during gel-filtration. The enzyme thrombin releases both
fibrinopeptide A and B from fibrinogen while the enzyme reptilase
exclusively releases the fibrinopeptide-A. The presence of
fibrinopeptide-B will not contribute to the coupling on the resin as its
NH2-terminal group is blocked and there are no lysines in its sequence
therefore there is no functional amino group in FP-B to join to resin
matrix. The stoichiometry of thrombin induced release of fibrinopeptides
from fibrinogen theoretically release 5.4 mg (3.52 micro moles)
fibrinopeptids-A from 1 gm of fibrinogen. The Sakaguchi test showed the
presence of 5.1 to 5.7 mg of fibrinopeptide A and B combined in
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cH 30H:H2o (75:25) extracts, which is about 50% of the theoretical yield.
The fibrinopeptide fraction from the gel-filtration indicated the
presence of 3.9 mg (36%) of fibrinogen. Under these circumstances of low
yields and a long procedure, it was decided to purchase fibrinopeptide-A
from Sigma Chemicals for further experiments.
2. Synthesis of Affi-FPA: Because fibrinopeptide-A is a highly acidic
protein (pi about 3), Affigel-15 which contain a cationic charge in the
spacer arm, has a significantly higher coupling efficiency than Affigel10 as shown in the experiment described below. Out of 2 mgs (1.3 uM) of
fibrinopeptide-A (from Sigma Chemicals), 1.63 mg was coupled to 5 ml of
Affigel-10 in CH 30H/ imidazole (0.05 M at pH 7.5) I 2.5 M CaC1 2
(7 .5/2.5/0.3) overnight at room temperature. In absence of ca+2 , the
coupling of FPA with Affigel-10 was negligible under identical
conditions. When Affigel-15 was used, almost all fibrinopeptide-A was
coupled at 4°C in one hour. Since Affigel-15 has 15 umoles /ml coupling
capacity, unreacted active groups were coupled with ethanolamine by
adding 3 ml 1 M ethanol amine after the fibrinopeptide-A coupling was
completed, and letting it react at room temperature for four hours.
After the reactions were completed, the resin gave a strong positive
Sakaguchi test, indicating the presence of the arginine containing FPA
on the resin.
~

Substitution

Q[

terminal Arginine Qy ALgal

1. Direct substitution: The synthesis of Affi-FPA-Argal was carried out
in three different ways. In the first approach Arg-Sc was directly
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substituted for arginine using carboxypeptidase-B as a transacylation
reagent and Arg-Sc as a nucleophile. In the second approach, arginine
was removed by carboxypeptidase-B and Arg-Sc was attached to
desarginine-FPA using a chemical method such as an active ester
procedure or a carbodiimide coupling procedure, with or without blocking
the side chain

coo-

groups of glutamates and aspartates. In the third

approach, the Affi-desArg-FPA was prepared followed by addition of ArgSc at the

coo-

terminal using an enzyme as tool to from a peptide bond.

The procedures utilized for the preparation of Affi-FPA-Argal using
carboxypeptidase-B are outline in Fig.22. It is difficult to monitor the
substitution reaction because of presence of large excess of Arg-Sc.
Since there is even exchange of guanidine group, the qualitative test
for guanidine groups on resin should remain the same. This leaves
aldehydic functional group as the only means to follow the substitution
reaction. Affigel is an agarose and gives some background towards tests
of aldehyde function, and since the concentration of exchanged Arg-Sc is
very low, an accurate estimation is extremely difficult. Despite this
difficulty, the qualitative test of resin with DNP indicated the
presence of a small amount of Arg-Sc.
Carboxypeptidase-B (CPB) catalyzes hydrolysis of the basic amino
acids lysine, arginine and ornithine from the C-terminal position in
polypeptides. Because of its high specificity for basic amino acids and
relatively very low activity towards other amino acids, it may be
possible to carry out trans-peptidation using CPB to exchange arginine
selectively. Since the free

coo-

end group is required for CPB action,
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Affi-Gel + Fibrinopeptides

1

CHjDH/0.05 M ]midazole pH 7.4
(75:25)

Affi-Gel--FPA

Carboxypeptidase-B
Arg-Sc
organic co-solvent
Arginine
Affi-Gel--Fibrinopeptide-A-Arg-Sc

1

cH30HJCH3COOHJHCHO
(7:1:2)

Affi-Gel--FPA-Argal

Figure-22. Synthetic scheme utilized in the synthesis
of a FPA-Argal liganded affinity resin using
carboxypeptidase-B and the Arg-Sc as a nucleophile.
(Direct substitution)
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the substituted FPA-Arg-Sc will not be a substrate for CPB and the FPAArg-Sc product, once formed, should be stable in the presence of CPB.
Sealock and Laskowski, 1969) utilized the same strategy to substitute
lysine for terminal Arg-64 in soybean trypsin inhibitor by CPB using a
large amount of trypsin as the product trapping reagent. Along with
trans peptidation, hydrolysis also occurs during the reaction because of
the competition of solvent water as a nucleophile. This competition
could be minimized by a large excess of Arg-Sc and the use of organic
solvent which inverses the equilibrium towards peptide bond formation.
The concentration of Arg-Sc is controlled by limited however, by the
solubility of the semicarbazone derivative, leaving organic solvent as
the major factor to promote peptide bond formation. Table 13 shows four
different combinations of organic solvents utilized for preparation of
Affi-FPA-Argal and the results observed for the binding of thrombin to
the product resin. The activities of unbound fractions (from 33 to 51 %)
indicate a lack of strong affinity of the column towards thrombin.
Mixed solvents using 1,4-butanediol or methanol produced better results
compared to ethylene glycol or ethylene glycol monomethyl ether.
Thrombin was retarded to a certain extent in all columns prepared by
this approach, but the binding characteristics of the columns were far
below expected levels.
2. Chemical Modifications: The procedures utilized for the
preparation of Affi-FPA-Argal using chemical modification are outlined
in Fig.23. The side chain

coo-

groups were blocked with ethanolamine

using a water soluble carbodiimide as a coupling agent, to prevent the

Table 13
Relative enzyme activities in 10 ml fractions of column effluents.
Resin: Affi-Gel--FPA-Ar1a1 (prepared by direct substitution using Carboxypeptidase-B)
Enzyme: Thront>i n
Buffer: 0.025 M Cacodylate containing 0.025 M CaC12 ,

0.01~

Carbowax 20M pH 6.0

S Enzyme activities

Eluting buffer

cn3oH!

E tylene

Ethylene
1, ll-butanediol
glycol
0.1 M NaHco3
(2:1)
100S
overnight
6 hours overnight

0. 1 N Nanco3 glycol
(1:1)
100S

overnight
Initial buffer (unbound)

51

73

77

0.2 M NaCl in buffer wash

51

10

10

1.0 M NaCl in buffer wash

0

0

33

25

0.1 M Semicarbazide containing

0.1 M NaOAc, 0.025 M CaC12 ,
0.01 ~ Carbowax 20M, pH 6.0

------------

0

0
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Affi-Gel + Fibrinopeptides

Jl Imidazole buffer pH 7.~
Affi-Gel-FPA

l

Ethanolamine
Water soluble carbodiimdde (EDAC)

Affi-Gel-FPA (ethanolamine)

l

Thrombin or Trypsin
Tris-pH-8.1
J~ Tenminal ethanolamine
Affi-Gel-FPA (ethanolamine)

l
l
l

Carboxypeptidase-B
in 0. 1M NaHC03

Affi-Gel-des Arg-FPA (ethanolamine)
Water soluble carbodiimide (EDAC)
+ Arg-Sc

Affi-Gel-FPA-Arg-Sc (ethanol amine)

CH30IVCH3COOHIHCHO

(7: 1 :2:)

Affi-Gel-FPA-Argal (ethanol amine)

Figure-23. Synthetic scheme utilized in the synthesis
of a FPA-Argal liganded affinity resin.
(Chemical method)
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coupling of Arg-Sc with side chain coo- groups. This procedure produces
an amide bond formed between the coo- and the NH2 of ethanolamine. The
COOH-terminal ethanolamine was removed by treating the resin with
trypsin which specifically hydrolyzes only the C-terminal Arginine-NHCH2-cH2oH bond generating a free coo- terminal. This coo- group is
crucial for CPB action in the removal of the COOH-terminal arginine from
fibrinopeptide-A and forming desArg-FPA. After a number of trials for
various lengths of time and different temperatures, it was concluded
that 40 minutes at room temperature is sufficient to remove most of
terminal arginine. The maximum amount of arginine released from the
Affi-FPA was 0.428 umoles (0.66 mg out of 1 mg total on the resin) in
the first 30 minutes of reaction. This quantitation of released arginine
is lower than its actual value because of interference from buffer
components during the Sakaguchi test for arginine. A qualitative test
for arginine on the resin after CPB treatment showed a very low amount
of residual arginine on the column. After 30 min of of reaction, the
residual arginine could not be remove even after 24 hr reaction at 37°C.
However the exposure of resin to CPB of more than 40 minutes at room
temperature could remove other terminal amino acids, producing
heterogeneous ligands on the resin.
The binding studies of thrombin with the resin were carried out in
a similar fashion as with the Affi-Phe-Pro-Argal resin. Table 14 shows
thrombin activities in various fractions of eluents during different
stages of preparation of the Affi-FPA-Argal resin. It could be seen that
while the virgin fibrinopeptide-A has some affinity towards thrombin, the
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Table 14
Relative enzyme activities in 10 ml fractions of col\Bl effluents.
Resin: Affi-Gel-FPA at various stages.
Buffer: 0.025 M Imidazole, 0.025 M CaC12 , 0.01S Carbowax pH 7.0
Enzyme: Thrombin

S Enzyme activity
Eluting buffer

Affi-FPA Affi-FPA Affi-FPA-Argal
Ethanol Ethanol amine
amine

Initial buffer (unbound)

68

0.2 M NaCl in buffer wash

14

6

11

1.0 M NaCl in buffer wash

0

0

0

0.1 M Semicarbazide containing
0.1 M NaOAc, 0.025 M CaC1 2 ,
0.01 S Carbowax 20M, pH 5.5
(overnight incubation)

2

50 ott Benzamidine in buffer

0

3 M KSCN

0
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ethanolamine treated fibrinopeptide-A does not have any affinity towards
thrombin and the ethanolamine treated fibrinopeptide-A-Argal prepared by
chemical method has high affinity towards thrombin. All efforts to elute
thrombin from the column failed including 3 M KSCN. It should be noted
here that this particular resin was reacted overnight with CPB to remove
terminal arginine,and only 30 minutes is required to remove all the
releasable terminal arginine. However, when only 40 minutes are allowed
for removal of terminal arginine to assure maximum homogeniety of the
peptide ligand, and

coo-

side chain groups are not blocked with

ethanolamine, lower affinity of the column to thrombin was observed
(Table 15).
An alternative to ethanol amine as a protecting group for

coo-

side

chains is the use of esters. These esters could be easily hydrolyzed
under basic conditions. Methyl esters are an attractive alternate to
ethanolamine groups which could be hydrolyzed easily above pH 10.5.
Proteins may be sensitive to the acidic conditions of the standard
esterification procedure which utilizes dry HCl in absolute methanol. In
addition to denaturation, there is always a danger of 0-alkylation and
N-alkylation reactions. It would be prefered to carry out the
methylation in an aqueous medium. However, the main difficulty in such a
procedure, is the competition of water with the protein for the reagent.
Trimethyloxonium tetra fluoro borate (TMOFB) was introduced by

Mee~wein

to selectively esterify carboxylic acids in aqueous solutions. This
reagent has been used to specifically modify the free carboxyl groups in
proteins at pH 4 to 5 (Osbahr, 1982; Peterson and Knowles, 1972; Hamada
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Table 15
Relative enzyme activities in 10 ml fractions of column effluents.
Resin: Affi-Gel-FPA-Argal (prepared by chemical method)
Enzyme: Thrombin
Buffer: 0.025 M Imidazole containing 0.025 M CaC12 ,
0.01 S Carbowax 20M. pH 7.0

S Enzyme activity
Eluting buffer
Affi-FPA-Argal
Initial buffer (unbound)

0

0.2 M NaCl in buffer wash

70

1.0 M NaCl in buffer wash

10
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Table 16
Relative enzyme activities in 10

m1

fractions of column effluents.

Resin: Affi-Gel-FPA-Argal (prepared with -OCH3 protection)
Enzyme: Throobin
Buffer: 0.025 M Imidazole containing 0.025 M CaClt,
0.01 S Carbowax 20M. pH 7.0

Eluting buffer

Initial buffer (unbound)

S Thrombin activity

64

0.2 M NaCl in buffer wash
1.0 M NaCl in buffer wash

n.d.
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and Yonemitsu, 1971). The half life of TMOFB in water at pH 4 to 5 is 10
minutes. This is sufficient time to selectively modify the free

coo-

groups in proteins in aqueous conditions.
Fibrinopeptide-A was modified with TMOFB as described in the
Methods Section and was reacted with Affigel. In the procedure a 100fold excess of reagent was dissolved in to dry acetonitrile and then
added slowly to the aqueous peptide solution. In order to achieve
maximum efficiency, the pH was controlled between 4.5 and 5.5 using 0.5
M NaOH. This modified fibrinopeptide-A was reacted with Affigel-15, as
described previously. In case of ethanol amine protection, the
modification is carried out after FPA was attached to the resin. This
was not done in esterification because maximum concentration could be
obtain in solution rather than in immobilized form on the resin during
its reaction with TMOFB. The terminal arginine methyl ester was
selectively hydrolyzed using thrombin or trypsin. The terminal arginine
was removed by action of CPB and Arg-Sc was added using EDAC at pH 4.5
where the esters are stable. The methyl ester protection of side chain

coo-

groups was removed at room temperature at pH 11.0. Table 16 shows

thrombin binding of different modified forms of the resin during the
synthesis of Affi-FPA-Argal using the methyl ester protection method.
From the Table 16 it is evident that the resin prepared in this way
lacks, a strong affinity towards thrombin.
3. Enzymatic synthesis: The procedure utilized for the preparation
of Affi-FPA-Argal using papain as reagent to form a peptide bond is
outlined in

Fig.~3.

In this approach the Affi-desArg-FPA resin was
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Affi-Gel 15 + Fibrinopeptide-A
CH~H/0.1 M NaHC0

4°C, 1 hour

3 (7 .5:2.5)

Ethanolamine pH 8. 0
Affi-Gel-FPA

l

Carboxypeptidase-B
0.1M NaHC0

3

40 min, room temperature

Affi-Gel--des Arg-FPA

1

Papain, pH-8.8 and 9.2

Arg-Sc

150 min, room temperature

1

Affi-Gel-FPA-Arg-Sc

CHj>HICH§OOHIIICID (7: 1 :2)

Affi-Gel-FPA-Argal

Figur--e-24. Synthetic scheme utilized in the synthesis
of a FPA-Argal liganded affinity resin.
(Enzymatic method)
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prepared as usual and the Arg-Sc added to the desarginine fibrinopeptide
ligand using papain, as described by Mitin

~ ~

(1984). In this

method, a low affinity between thrombin and Affi-FPA-Argal (Table 17)
was observed. Qualitative test for presence of arginine showed very
little arginine on the column by the the Sakaguchi test.
4J. Separation of urokinase from thrombin on Affi-FPA-Argal column:
Since both proteinases has different specificity, urokinase should
not show an affinity towards Affi-FPA-Argal resins. Even though
appreciable affinity was not observed in any of the preparations, the
resin prepared without protecting side chain

coo-

groups (chemical

method) showed some affinity towards thrombin. This preparation was
utilized to try to separate urokinase and thrombin from a mixture. Table
18 shows the activities of thrombin and urokinase in different fractions
of elution of a 84 units of thrombin and 500 units of urokinase over
Affi-FPA-Argal column. The procedure was same as described for the
separation of two proteases over Affi-Phe-Pro-Argal column. The resin
showed slightly greater affinity towards thrombin than to urokinase, but
the difference is too small for practical purposes.
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Table 17
Relative enzyme activities in 10 m1 fractions of column effluents.
Resin: Affi-Gel-FPA-Argal (prepared by enzymatic method)
Enzyme: Thrombin
Buffer: 0.025 M Imidazole containing 0.025 M CaC1 2 ,
0.01 ~ Carbowax 20M. pH 7.0

--------------------------------------------------Eluting buffer

J Thrombin activity

Initial buffer (unbound)

20

0.2 M NaCl in buffer wash

65

1.0 M NaCl in buffer wash

n.d.
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Table 18
Relative enzyme activities in 10 ml fractions of column effluents.
Resin: Affi-Gel-FPA-Argal (prepared by chemical method)
Enzyme: Mixture of Thrombin and Urokinase.
Buffer: 0.025 H Lmidazole containing 0.025 H CaC12 ,
0.01 S Carbowax 20M. pH 7.0

S Enzyme activity

Eluting buffer

Thrombin

Urokinase

Initial buffer (unbound)

17

62

Additional 10 ml of
initial buffer wash

1

2

0.2 M NaCl in buffer wash

55

CHAPTER V

DISCUSSION

~

Preparation

Q(

affinity resins

1. Argal as ligand: Argal resins could be synthesized either by

cooarginine coo-

immobilization of arginine onto the resin followed by reduction of
group of arginine to an aldehydic group or by reducing the

prior to immobilization. There are a number of technical difficulties in
the first approach such as possible side reactions with the matrix and
the physical separation of side products or solid reagent catalysts. The
second approach appears technically more feasible and cleaner. It also
allows characterization of ligand prior to its immobilizationan on the
resin.
Since the work was started in 1979, a number of new syntheses have
been reported forO(-aminoaldehydes from amino acids and alcohols. The
chemo selective reduction of acids to aldehydes (Fujisawa

~ ~.

1983)

and the oxidation of N-protected)5-amino alcohols using a combination of
sulfur trioxide-pyridine complex and DMSO in the presence of triethyl
amine to optically active o(-amino aldehydes (Hamada and Shoiri, 1982)
are good examples of new synthetic procedures. These techniques allow
preparation of optically activeo(-amino aldehydes from most of the amino
acids and the preparation of peptide aldehydes to be used as specific
inhibitors.
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In this work preparation of affinity resin containingQ(-amino
argininals as a ligands have been established. Possibilities still to be
explored include the use of phenylalaninal as a ligand in affinity resin
for the purification of proteases with chymotrypsin-like specificity.
In preparation of affinity resins the spacer arm plays very
important role in binding efficiency. When (Gly)n-Tyr-NH2 was used as
ligand to bind chymotrypsin, the resin did not show affinity when n:O.
The resin only showed affinity with n=3 or 4 (Blumberg and KatchalskiKatzier, 1979). This type of steric effect of the resin in preventing
association of the enzyme where the ligand is bound directly to the
resin may be one of the reasons for the failure to of the EnzacrylArgininal resin to bind trypsin, as no spacer arm group was present. In
addition to the length of the spacer arm, the ionic character of the
spacer arm is also important. This is demonstrated by the increased
efficiency of coupling of the negatively charged fibrinopeptide-A with
Affigel-15 containing a positively charged spacer arm, with respect to
its binding to the Affigel-10.
The Sakaguchi test for guanidine group is convenient for
qualitative and quantitative determinations of arginine. The extreme
ease and speed of the test is useful in monitoring reactions involving
guanidine group. During the removal of the N02 guanidine protection with
hydrogenolysis it was important to remove the N02 protection and limit
any undesirable reduction of the C:N Schiff's base double bond. The
Sakaguchi test was necessary in monitoring this deprotection reaction.
In addition to the guanidine group monitoring, aldehydic assays were
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also crucial during hydrogenolysis. Preliminary work indicated that this
could be easily accomplished spectrophotometrically using
pararosaniline. Quantitation of aldehydic function on the resin may not
be accurate because the reaction of p-phenyl azoaniline with aldehyde
may not go to completion and its subsequent transfer to salicyl aldehyde
might also fall short of complete reaction. This test establishes a
minimum value for the presence of aldehydic group. Affi-Argal showed
minimum of 0.1

~m/ml

of aldehyde by this test. Considering a 1:1

stoichiometry between trypsin and Argal, the resin could bind 2.5 mg of
trypsin per ml of resin. The theoretical capacity of the resin is 375 mg
of trypsin per ml of resin based on 15pm/ml of resin. However, it is
impossible to achieve this binding capacity due to steric reasons. At
our minimal capacity of 2.5 mg trypsin/ml resin,

3 ml of column can

purify significant quantities of protease in pure form. In comparison, a
3 ml gel-filtration or ion-exchange column could only obtain a small
amount of pure enzyme.

5a

Procedure fQr purification

Q(

serine

utilizing

Q(

£ protease reaction

~ ~

product

QL

cysteine proteases

A number of biological events are controlled by proteolytic action.
In many instances the product of a biologically important proteolytic
action is known and well characterized, but the protease itself has not
been defined or characterized. For example during the induction of lytic
growth of the Escherichia

~

prophage lambda, the C1-repressor protein

is cleaved. The hydrolysis products of this reaction are well
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characterized (Roberts and Devoret, 1983). Rec-A protein is belived to
play an important role in this process. The proteolytic cleavage occurs
between alanine and glycine in comparable positions of the four
polypeptides of repressor protein. Affinity resins could be prepared for
purification of the protease responsible for the proteolytic process in
similar fashion as described for fibrinogen-thrombin reaction. This
could be done by immobilizing repressor on a resin and cleaving the
repressor with a cell lysate solution containing the protease, followed
by the conversion of the newly formed COOH-terminal alanine to alaninal.
A presupposition here is that the protease is a serine or cystine
protease.
The example of fibrinogen-thrombin is described in this work.
Immobilization of neutral proteins or peptides do not present a major
problem with most of the matrices, but highly basic or acidic proteins
or peptides need a careful selection of the matrix or spacer arm.
Immobilization of the highly acidic fibrinopeptide-A was very efficient
with Affigel-15, which contains a positively charged spacer arm. With
the Affigel-10, which contains a neutral spacer arm, appreciable
coupling was obtained only after addition of ca+2 to the coupling
solution. Monitoring the coupling reaction with Sakaguchi test provides
· both qualitative and quantitative results. Since most proteins contain
arginine, this test could be adopted for monitoring coupling reactions
between proteins and matrix. Large proteins may not require a spacer arm
for efficient binding, if the protease binding site in the protein
substrate is reasonably far away from the matrix.
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Modification

Q(

CQQH-terminal peptidyl amino

~tQ£n

aldehydic

function.
In the biosynthesis of leupeptin, the leupeptin acid is reduced to
leupeptin by leupeptin acid reductase (Umezawa and Aoyagi, 1983). This
membrane bound enzyme could perhaps be used to reduce terminal

coo-

groups. However, since the enzyme is membrane bound, it is difficult to
use in in the laboratory preparation of Argininal. In addition it
appears specific to the Leu-Leu-Arg sequence. The chemical approaches
taken in this work for substituting the terminal amino acid by the
corresponding amino aldehyde are more practical and general.
The direct substitution of Arg-Sc using carboxypeptidase-B seemed
to be a better alternate than to use carboxypeptidase-Y or other
carboxypeptidases. Since the rate of removal of a terminal amino acid by
carboxypeptidase-B is much higher for basic amino acids, there is a much
higher probability of obtaining a homogeneous ligand. The penultimate
amino acid in fibrinopeptide-A is valine and carboxypeptidase-B has a
low activity towards valine. The use of carboxypeptidase-Y in trans
peptidation reactions produced complex mixtures of products (Breddam

~

Ql., 1981). In addition to the carboxypeptidase activity,

carboxypeptidase-Y has an amidase activity, which resulted in the
subsequent formation of secondary products.
Addition of organic co-solvents or change in pH or ionic strength
of the buffer changes the equilibrium constant between hydrolysis and
amidation. Addition of methanol or 1,4-butanediol to the reaction media
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thus alters the equilibrium catalyzed by carboxypeptidase-B in favour of
transpeptidation.
The resin Affi-FPA-Argal produced by carboxypeptiase B with added
Arg-Sc nucleophile in 1,4-butanediol showed some affinity towards
thrombin. This affinity is not high enough to be useful, but the low
activity could be solely due to a low total concentration of the
desirable ligand, FPA-Argal.

The DNP test on the resin showed the

presence of very little aldehydic function.
Affi-FPA-Argal resins prepared by chemical procedures showed a
higher affinity towards thrombin (Tables 14,15). Although the pKa's of
side chain

coo-

and terminal

coo-

groups are expected to be different,

it is difficult to join Arg-Sc on just the terminal

coo-

selectively.

This could be accomplished only by first blocking the side chain
groups by methylation or with ethanolamine. Blocking the

coo-

coo-

sidechain

groups by methylation results in decrease solubility of the protein, but
since the reaction was carried out in 75% methanol, this appears not to
pose a problem.
After modification of all the free carboxyls by methylation, the
terminal

coo-

was generated by the treatment with trypsin or thrombin,

both enzymes serve the same purpose. In case of an unknown protease the
biological solution containing the protease could be used to generate
the terminal

coo-

group.

To remove the terminal amino acid, carboxypeptidase proteases are
an excellent reagents. An appropriate carboxypeptidase has to be
selected for efficient removal of just the·terminal amino acid. The
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time, concentration and temperature conditions need to be carefully
worked out. In the

cas~

of carboxypeptidase-a, the high selectivity for

basic amino acids provides a very convenient method of selectively
removing the terminal arginine. Also the reaction is easy to monitor
with the Sakaguchi test. However, small residual amount of arginine
remained on the resin, even after overnight treatment at 37 °C. The
arginine remained perhaps because some arginine may not be accessible
to CPB due to steric reasons. The work presented establishes the
procedure to remove terminal arginine and also a method for monitoring
the reaction is described.
After addition of Arg-Sc to the des-Arginine <&(and

~-methyl)

FPA, the removal of the methyl group protection of from the side chain

coo-

groups is important in order to restore the substrate to its

natural form.

Ethanolamine protection is not possible to selectively

remove. The methyl esters are labile at basic conditions and treatment
with sodium carbonate at pH 11 may be safe and effective for most
protein substrates. Proteins and peptides can usualy survive this basic
conditions for a short time without denaturation.
Enzymatic synthesis, contrary to chemical synthesis, does nor
require a special activation of the carboxyl group. Also a consequence
of this specificity functional side groups of amino acids do not have to
be protected. The additional advantages of enzymic synthesis are stereo
specificity and milder reaction conditions. Since the penultimate amino
acid in fibrinopeptide-A is valine, neither trypsin nor chymotrypsin
have a primary specificity for the terminal amino acid and hence can not
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be utilized as reagents.
In thermolysin catalyzed peptide bond synthesis, the enzyme
exhibits preference for a hydrophobic amino acid as the donor of the
carboxyl group for the newly formed bond (Wayne and Fruton, 1983). The
relative rate of the peptide bond synthesis with Z-Val-OH was observed
to be 0.03 % compared to Z-Phe-OH. This indicates that thermolysin is
not a good choice for formation of a Val-Arg-Sc bond.
Papain has broad primary specificity towards substrates and
therefore was selected as a possible reagent to form the Val-ArgSc bond.
The kinetic approach described by Mitin

~ ~

(1984) was used at pH

9.2. This pH value was selected to minimize hydrolysis of
fibrinopeptide-A and to maximized formation of the peptide bond between
desarginine fibrinopeptide-A and Arg-Sc. The peptidase activity of
papain above pH 8.0 is negligible, but the synthesis activity at this pH
is high. However, the Sakaguchi test on the resin Affi-FPA-Argal
prepared by this method showed very little argininal present on the
resin. In the pilot experiments by Mitin to establish the reaction
conditions, protected amino acid methyl esters and dipeptide methyl
esters were used(Mitin

~ ~

1983). In addition, Mitin found

the rate

of synthesis is generally inversly proportional to the length of

coo-

donating peptide. With respect to the amine component, dipeptides are
better nucleophiles than mono amino acids or other small amines (Mitin
~ ~

1983; Bajkowski and Frankfater, 1983; Petkove and Stoineva,

1984). DesargFPA is 15 amino acids long and therefore the rate of
synthesis may be expected to be slow, and

the nucleophile Arg-Sc is
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only a mono amino acid making it disadvantageous from both sides.
Among all the three different approaches to substitute ArgSc for
arginine in Affi-FPA, the chemical synthetic approach showed some
success, with a minimum of 66% removal of terminal arginine by CPB
followed by high degree of addition of Arg-Sc to the desArg ligand. The
total concentration of the FPA on the resin is 0.6 nanamoles/ml, and
after chemical modification, the concentration of FPA-Argal could be as
much as 0.4 nanamoles/ml. This is a low concentration compare to
tripeptide aldehyde resins (0.1 to 0.21 micromoles). It translates into
a capacity of 0.034 mg (75 units) of total thrombin binding capacity.
This capacity of the resin could be increase by increasing the ligand
concentration.
Nishikata

~ ~

(1981) and Ishii and Kasai (1981) have previously

reported the preparation of Leu-Argal and Gly-Gly-Argal affinity resins
for purification of Streptomyces grieses trypsin and bovine trypsin. In
their work, strong acid was used to decomposed a semicarbazone
derivatized resin to free aldehyde and either strong acid (50 mM HCl) or
1x1o- 4 M leupeptin was used to elute the tightly bound trypsins from the
resins. In the leupeptin containing buffers, the dissociated enzyme is
eluted as an inhibited complex with the leupeptin inhibitor. The
leupeptin then needs to be dialyzed or destroyed by NaBH 4 reduction
before the appearance of catalytic activity in the eluted fractions.
In this work, it was found that treatment of our resins with a
strong acid was destructive of the trypsin binding properties to the
resin. However, the removal of the semicarbazone protection in acetic
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acid/methanol/formaldehyde, as described, was found to be nondestructive as repeated treatments with this reagent did not have any
detrimental effect on proteinase affinity. Furthermore, the removal of
tightly bound proteases with semicarbazide containing buffers rather
than buffer containing proteinase inhibitors has the advantage of not
requiring additional steps before the generation of a catalytic activity
in the eluted enzyme fractions. Nonspecific adsorption of enzyme on the
resin and the glassware was prevented by including a surfactant,
carbowax-20M, in the buffer.

5D

Association

Q[

proteases tQ affinity resins.

As argued in Chapter 2, the the peptidyl aldehyde ligands associate
serine proteases by forming a reversible covalent hemiacetal with the
active site serine, as shown in Fig.2, where E-OH is the active site
serine o-OH of the enzyme and RCH:O the peptidyl aldehyde. The rate of
hemiacetal formation has been shown in the serine proteinase
chymotrypsin to be general base-specific acid-catalyzed, as depicted in
Fig.2 (Kennedy and Schultz, 1977) and the hemiacetal (IIB in Fig.2) has
a similarity to the tetrahedral intermediate and/or transition state
formed during substrate catalysis (Kennedy and Schultz, 1977; Thompson,
1973; Chen

~ ~

1979; Thompson and Bauer, 1979). The free energy for

aldehyde association is much greater in the enzyme active site
(approximatly 2.8 to 3.0 Kcal/mole) for aldehydes with a specific P1
side chain than for their amide substrate analogs (Thompson and Bauer,
1979). Based on this value, peptide aldehyde will associate about 1000
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fold strongly to the enzyme than the same peptide without the aldehydic
group. From X-ray crystallography, non-covalent complexes between serine
proteases and specific ligands are characterized by low internal
mobility, and covalent reactions within these complexes should therefore
occur with abnormally favourable entropies of reaction (James

~ ~

1980). In the case of a protease catalyzed substrate hydrolysis, the
transition-state is a high energy ester with a pyramidal carbonyl carbon
atom and with the carbonyl oxygen remaining in the strongly polarizing
electrostatic field of the oxyanion hole. Contrary to this, in case of
peptide aldehydes, the hemiacetal is a low energy complex with a
protonated oxygen in the oxanion hole (productive mode in Fig 6) or the
aldehydic

c1

hydrogen in the oxyanion hole (non-productive mode in Fig

6).
The high affinity of the aldehyde ligands to serine proteases is
supported by the affinity of the Affi-Argal resin to trypsin, which
is significantly greater than to an affinity resin in which trypsin is
associated non-covalently. This is shown by the ability to elute trypsin
from the non-covalent affinity resins such as lysine or benzamidine
liganded resins by high salt and/or low pH, where as the Affi-Argal
resin binds trypsin irreversibly under these conditions. In addition to
the aldehydic function, the importance of side chain interactions is
clearly demonstrated by the preferential affinity to trypsin over
chymotrypsin, which clearly shows that the guanidinium group is also
required for the selectivity and specificity of binding.
The Affi-Argal resin serves as a model for the preparation of
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highly effective affinity resins using specific peptidyl aldehyde
ligands. The tighter binding to the Argal ligand than to non-covalent
binding resins show that the Argal resin can be used for the affinity
purification or inhibition of proteases at low protease

concentrations.

In addition, as peptidyl aldehydes do not show any significant pH
dependency between pH 3 and 8 for association of proteases, affinity
purification of proteases can be carried out at pH<7.0 at which pH
values most proteases are catalytically inactive and, thus,
autocatalytic degradation will not be of consequence.
By keeping Argal in the terminal position and extending the ligand
towards the N-terminal, the specificity of the ligand was increased to
discriminate between proteases in the same class. The combination of
secondary specificity with the aldehydic function makes these ligands
highly specific and potent inhibitors. Thus, the peptide aldehyde D-PhePro-Argal has shown to have a binding constant towards thrombin of
between 4.5x1o-7 and 7.5x10-8M (Bajusz ~ ~ 1978; Fareed ~
~1981).

As peptide argininals in water are in equilibrium with its

aldehyde hydrate and with a tautomeric carbinolamine structure formed by
the reversible addition of the guanidine nitrogen to the aldehyde
function, the concentration of free aldehyde available to participate in
the equilibrium with the enzyme has been shown by NMR to be 1% of the
total concentration of the peptide in aqueous solution (Kozlowski and
Schultz, unpublished results). Accordingly, based on the concentration
of free aldehyde, the true Ki for the binding of D-Phe-Pro-Argal is in
the range of 1o-11M. The binding constant to L-Phe-Pro-Argal is
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estimated to be 100 fold poorer than for D-Phe-Pro-Argal to thrombin
(Bajusz

~ ~1978).

Thus, the corrected binding constant to the Phe-

Pro-Argal ligands in Affi-Phe-Pro-Argal can be estimated to be near 10-8
to 1o-1° M. Similarly the estimated binding constant of Affi-Gly-GlyArgal is expected to be near 10-7 to 10-8 M (Ahsan, Pagast and Schultz,
unpublished results). These low values of Ki for the binding of specific
peptidyl argininals to proteinases approach those binding constants
observed between an antibody and an antigen. Even lower values of Ki
than to the serine proteinases can be calculated for peptidyl aldehyde
binding to cysteine proteases (Westerick and Wolfenden, 1972; Frankfater
and Kuppy, 1981). Accordingly, the peptidyl aldehyde liganded resins
will have an extremely high affinity to both serine and cysteine
proteases and can potentially be utilized to purify proteinases present
in very low concentrations in biological fluids.
The ability to bind a particular proteinase by variation of X-Y
represents an amplification of normal peptide binding specificity
similar to that previously observed for peptide aldehyde inhibitors of
chymotrypsin, elastase and papain (Thompson, 1973; Kennedy and Schultz,
1979; Thompson and Bauer,1979; Wolfenden, 1972). For example, in the
case of chymotrypsin, an increased affinity of approximately 140-fold
can be calculated for the binding of the specific aldehyde Bz-L-Pheal
over that of the non-specific aldehyde hydrocinnamaldehyde (after
correction for hydration), whereas the respective Ks values for the
substrates Bz-L-Phe-NH2 and hydrocinnamide differ by a factor of only
two (Kennedy and Schultz, 1979; Schultz and Cheerva, 1975). This
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amplification of normal differences in binding affinities for specific
aldehyde ligands over non or less-specific aldehyde ligands is due to an
increse in the ratio of k2 /k_ 2 in fig-2, and may reflect the greater
complementarity of the more specific analog to the transition state
configuration of the enzyme.
I had a limited success with fibrinopeptide Argininal resins. The
tighter binding was observed in a case in which overnight reaction with
carboxypeptidase-B was carried out to prepare desArg-FPA on the resin.
In this case the exact nature of the ligand is unknown, but irreversible
binding was observed. In other preparations, where the nature of ligand
could be predicted to be FPA-Argal with a certain certainty, the
affinity is poor for thrombin. In our prediction of a high affinity for
the ligand, we are assuming that the conformation of product (P2 ) is
retained, as in the parent protein molecule, even after proteolytic
cleavage and also after its immobilization on the matrix. Pentamer to
decamer peptides form inter molecular)3-structure in the solid state and
in some solvents; and an eicosapeptide exhibits a high percentage of (7(helical structure both in the solid state and in solution (Toniolo et
al, 1984). X-ray analysis of a linear hexa and octa peptides suggests
formation of a hairpin shaped conformation stabilized by multiple intramolecular H-bonds (Bavaso

~ ~

1982; Lagant

~ ~

1984). However

the immobilized fibrinopeptide-A-Argal may assume a stable conformation
which could be different from fibrinopeptide-A portion of fibrinogen. In
addition after proteolytic cleavage, conformation changes often occur in
the protein around the proteolytic cleavage site.

For example, a
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monoclonal antibody study shows that the amino terminus of theA~chain
in human fibrin exhibits a different conformation than in human
fibrinogen (Hui and Haber, 1983). If the proteolytic cleavage occurs
between two domains of a large protein the conformational change may not
be drastic. Thus the example of fibrinopeptide-A-thrombin could be a
poor choice to demonstrate the idea of a general procedure to prepare
affinity resins using aldehyde transition state analog. Other cases,such
as the plasminogen-plasminogen activator system, might prove to be more
successful.
As many trypsin-like proteinases often coexist in a particular
biological compartment or pathway (Reich

~ ~

1975), it is of

importance to be able to separate a particular trypsin-like proteinase
from other proteinases of similar primary binding site specificity for
arginine or lysine. This work shows the ability of the R-(X-Y-Argal)
resins to separate a particular serine proteinases (thrombin or
urokinase) from a solution containing a mixture of two proteinases of
identical primary binding specificity for arginine. Accordingly, from an
£ prioi knowledge of an arginine specific proteinase's secondary binding

site specificity, a R-X-Y-Argal sequence can be designed to selectively
separate a proteinase of interest.

SUMMARY

The purification of proteolytic enzymes from biological systems is
often difficult, especially when the concentration of the enzyme is low
and multiple enzymes with an identical primary specificity are present.
One of the more promising techniques for protease purification is
affinity chromatography. I have synthesized a new family of affinity
chromatography ligands consisting of peptides containing the aldehyde
analog of arginine in the C-terminal position. Upon association with the
serine protease, such peptide aldehydes mimic features of the
transition-state configuration of substrates during hydrolysis and hence
will be expected to associate with extremly high affinity and
specificity as predicted for transition-state analogs.
The aldehyde analog of arginine was synthesized by reduction of
Cbz-N02-Arginine with LiAlH 4 in tetrahydrofuran in presence of 1,1'carbonyldiimidazole at -70 °C. The aldehydic function was protected by
forming a semicarbazone derivative, which served as a stable
intermediate. Cbz and N02 protections were removed by catalytic
hydrogenation in the presence of palladium black. Arginine semicarbazone
was immobilized on Affi-Gel-10 through a stable amide bond. The resin
showed extremly high affinity toward trypsin and no affinity towards
chymotrypsin. The trypsin activity remained bound to the resin even
after exhaustive washing.
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To exploit secondary specificity of proteases, affinity resins of
the general formula R-X-Y-Arginal (where R- is resin matrix and -X-Y- is
a dipeptide) were synthesized. The tripeptide synthesis on the resin was
N-terminal to C-terminal, which is opposite from the commonly utilized
Marrifield solid phase peptide synthesis. The conditions for binding and
elution from Affi-X-Y-Arginal resins (-X-Y-

= Phe-Pro,

Phe-Ala and Gly-

Gly) of the serine proteases trypsin, thrombin and urokinase are
described in this work. In all cases in which the peptidyl argininal
showed a high specificity to a particular protease (i.e., Gly-GlyArginal for urokinase and Phe-Pro-Arginal for thrombin), the protease
could not be removed with high ionic strength buffers. Urokinase and
thrombin could be separated from one another and purified by either an
Affi-Phe-Pro-Arginal or an Affi-Gly-Gly Arginal affinity column. A
method to elute the tightly bound proteases in an active form was
established using 0.1 M semicarbazide containing 0.1 M sodium acetate,
0.025 M Cac1 2 and 0.01 %Carbowax 20M. The resin could be regenerated
repeatedly without loss of its protease binding capacity by overnight
treatment with methanol/ acetic acid/ formaldehyde.The concentration of
Arginine aldehyde was determined by p-aminoazoaniline and salicyaldehyde
system and showed a minimum of 0.1 micromole/ ml of resin. Based on this
value, the protease binding capacity of the resin is 2.5 mg of trypsinlike protease/ ml of resin.
A general procedure for purification of proteases in which acid
product of a specific substrate of the the protease is attached by its
N-terminal residue to an inert support and the COOH-terminal amino acid
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modified to a peptide aldehyde to generate the transition-state analog
inhibitor of the protease of interest is descried. A particular case of
fibrinopeptide-A to purify thrombin was investigated with limited
success, perhaps due to very low concentration of the ligand on the
affinity resin. Three different approaches to substitute the terminal
arginine in fibrinopeptide-A by Arginine semicarbazone were investigated
including (i) direct substitution, (ii) chemical method and (iii)
enzymatic method.
These transition-state affinity purification technique should have
a general usefulness in the isolation and purification of biologically
important proteases for therapeutic use in coagulation disorders.
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